nach oben

Erschienen in:

2021 | Pädiatrische Hämatologie und Onkologie | OriginalPaper | Buchkapitel

6. Besondere Patientengruppen und praktische Herausforderungen

verfasst von : Georg Rellensmann, Ingeborg van den Heuvel, Kerstin von der Hude, Lars Garten, Silke Nolte-Buchholtz, Boris Zernikow, Mandira Reuther, Jens Berrang, Thomas Berger, Carola Hasan, Michael C. Frühwald, Tim Niehues, Ulrich Neudorf, Anne Schönecker, Uta Schürmann, Uwe Mellies, Heike Bredow, Caroline Gauch-Ayar, Michael Frosch, Bettina Hübner-Möhler, Andrea Beissenhirtz, Almut Hartenstein-Pinter, Hauke Schumann, Arne Simon, Pia Schmidt, Anna Kämper, Birgit Mertens, Barbara Gertz

Erschienen in: Pädiatrische Palliativversorgung – Grundlagen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Das Spektrum an lebenslimitierenden Erkrankungen im Kindesalter ist sehr breit gefächert. Es reicht von seltenen genetischen Erkrankungen, angeborenen/erworbenen Anomalien und (Mehrfach-) Behinderungen über neurologische Symptomenkomplexe bis hin zu Krebserkrankungen. Genauso weit sind auch das Altersspektrum pädiatrischer Palliativpatienten und so unterschiedlich sind die Versorgungsorte, an denen uns diese Patienten und ihre Familien begegnen. Das Kapitel beschreibt, wie eine gute palliative Versorgung gelingen kann - ob schon perinatal, in der Neonatologie, auf der pädiatrischen Intensivstation oder beim Übergang in das Erwachsenenleben. Zusätzlich bietet es viel Information zu den wichtigsten Themenkomplexen in der pädiatrischen Palliativversorgung, wie z. B. bei chromosomalen und metabolischen Störungen, neuro-muskulären Erkrankungen, schweren Mehrfachbehinderungen u. v. a. m. Der Fokus in diesem Kapitel liegt vermehrt auf den palliativ-psycho-sozialen Aspekten, detaillierte Angaben zur medikamentös-medizinischen Behandlung finden sich in der gesonderten Ausgabe Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle.

Adler K, Schlieper D, Kindgen-Milles D et al (2017) Integration der Palliativmedizin in die Intensivmedizin. Anaesthesist 66:660–666PubMedCrossRef

Boss R, Nelson J, Weissman D et al (2014) Integrating palliative care into the PICU: a report from the Improving Palliative Care in the ICU Advisory Board. Pediatr Crit Care Med 15(8):762–767PubMedPubMedCentralCrossRef

Bülow H-H, Sprung CL, Reinhart K et al (2008) The world’s major religions’ points of viewon end-of-life decisionsin the intensive care unit. Intensive Care Med 34(3):423–430PubMedCrossRef

Committee on Hospital Care, Institute for Patient-and Family-Centered Care (2012) Patient-and family-centered care and the pediatrician’s role. Pediatrics 129(2):394–404CrossRef

Davidson JE, Aslakson RA, Long AC et al (2017) Guidelines for family-centered care in the neonatal, pediatric, and adult ICU. Crit Care Med 45(1):103–128PubMedCrossRef

Dryden-Palmer K, Moore G, McNeil C et al (2020) Moral distress of clinicians in Canadian pediatric and neonatal ICUs. Pediatr Crit Care Med 21(4):314–323PubMedCrossRef

Edwards JD, Voigt LP, Nelson JE (2017) Ten key points about ICU palliative care. Intensive Care Med 43(1):83–85PubMedCrossRef

Everhart JL, Haskell H, Khan A (2019) Patient-and family-centered care: leveraging best practices to improve the care of hospitalized children. Pediatr Clin 66(4):775–789

Feudtner C (2007) Collaborative communication in pediatric palliative care: a foundation for problem-solving and decision-making. Pediatr Clin N Am 54(5):583–607CrossRef

Garten L, Globisch M, von der Hude K et al (2020) Palliative care and grief counseling in peri-and neonatology: recommendations from the German PaluTiN Group. Front Pediatr 8:67PubMedPubMedCentralCrossRef

van den Heuvel I, Nolte-Buchholtz S, Rellensmann G (2019) Pädiatrische. Intensiv-und Palliativmedizin–unsere Patienten brauchen beides! Intensivmedizin up2date 15(01):91–110

Humphrey L, Schlegel A, Seabrook R et al (2019) Trigger criteria to increase appropriate palliative care consultation in the neonatal intensive care unit. Pediatr Qual Saf 4(1):e129PubMedPubMedCentralCrossRef

Institute of Medicine, Committee on Approaching Death (2015) Improving quality and honoring individual preferences near the end of life. National Academies Press, Washington, DC

Lutmer JE, Humphrey L, Kempton TM et al (2016) Screening criteria improve access to palliative care in the PICU. Pediatr Crit Care Med 17(8):e335–ee42PubMedCrossRef

Madrigal VN, Patterson Kelly K (2018) Supporting family decision-making for a child who is seriously ill: creating synchrony and connection. Pediatrics 142(3):170–177CrossRef

Marc-Aurele KL, English NK (2017) Primary palliative care in neonatal intensive care. Semin Perinatol 41(2):133–139PubMedCrossRef

Meert KL, Clark J, Eggly S (2013) Family-centered care in the pediatric intensive care unit. Pediatr Clin 60(3):761–772

Morrison WE, Gauvin F, Johnson E et al (2018) Integrating palliative care into the ICU: from core competency to consultative expertise. Pediatr Crit Care Med 19(8S):S86–S91PubMedCrossRef

Moynihan KM, Snaman JM, Kaye EC et al (2019) Integration of pediatric palliative care into cardiac intensive care: A champion-based model. Pediatrics 144(2):e20190160PubMedCrossRef

Nelson JE, Curtis JR, Mulkerin C et al (2013) Choosing and using screening criteria for palliative care consultation in the ICU: a report from the Improving Palliative Care in the ICU (IPAL-ICU) Advisory Board. Crit Care Med 41(10):2318–2327PubMedCrossRef

October T, Dryden-Palmer K, Copnell B et al (2018) Caring for parents after the death of a child. Pediatr Crit Care Med 19(8):S61PubMedPubMedCentralCrossRef

Opel DJ (2018) A 4-step framework for shared decision-making in pediatrics. Pediatrics 142(Suppl. 3):S149–SS56PubMedCrossRef

Prentice T, Janvier A, Gillam L et al (2016) Moral distress within neonatal and paediatric intensive care units: a systematic review. Arch Dis Child 101(8):701–708PubMedCrossRef

Richards CA, Starks H, O’Connor MR et al (2018) When and why do neonatal and pediatric critical care physicians consult palliative care? Am J Hosp Palliat Med 35(6):840–846CrossRef

Sabatello M, Janvier A, Verhagen E et al (2018) Pediatric participation in medical decision making: optimized or personalized? Am J Bioeth 18(3):1–3PubMedPubMedCentralCrossRef

Sidebotham P, Fraser J, Fleming P et al (2014) Patterns of child death in England and Wales. Lancet 384(9946):904–914PubMedCrossRef

Trowbridge A, Walter JK, McConathey E et al (2018) Modes of death within a children’s hospital. Pediatrics 142(4):e20174182PubMedCrossRef

de Vries M, Fagerlin A, Witteman HO et al (2013) Combining deliberation and intuition in patient decision support. Patient Educ Couns 91(2):154–160PubMedCrossRef

Wiener L, McConnell DG, Latella L et al (2013) Cultural and religious considerations in pediatric palliative care. Palliat Support Care 11(1):47–67PubMedCrossRef

Balaguer A, Martín-Ancel A, Ortigoza-Escobar D et al (2012) The model of palliative care in the perinatal setting: a review of the literature. BMC Pediatr 12(1):25PubMedPubMedCentralCrossRef

Barton L, Hodgman JE (2005) The contribution of withholding or withdrawing care to newborn mortality. Pediatrics 116(6):1487–1491PubMedCrossRef

Caeymaex L, Jousselme C, Vasilescu C et al (2013) Perceived role in end-of-life decision making in the NICU affects long-term parental grief response. Arch Dis Child Fetal Neonatal Ed 98(1):F26–F31PubMedCrossRef

Campbell-Yeo M, Fernandes A, Johnston C (2011) Procedural pain management for neonates using nonpharmacological strategies: part 2: mother-driven interventions. Adv Neonatal Care 11(5):312–318PubMedCrossRef

Carter BS (2018) Pediatric palliative care in infants and neonates. Children 5(2):E 21

Carter BS, Brunkhorst J (2017) Neonatal pain management. Semin Perinatol 41(2):111–116PubMedCrossRef

Chin WL, Jaaniste T, Trethewie S (2018) The role of resilience in the sibling experience of pediatric palliative care: what is the theory and evidence? Children 5(7):E 97

Côté-Arsenault D, Denney-Koelsch E (2011) „My baby is a person“: Parents’ experiences with life-threatening fetal diagnosis. J Palliat Med 14(12):1302–1308PubMedCrossRef

Craig F, Abu-Saad HH, Benini F et al (2008) IMPaCCT: standards pädiatrischer Palliativversorgung in Europa. Z Palliativmed 9(2):61–66CrossRef

Craig J, Glick C, Phillips R et al (2015) Recommendations for involving the family in developmental care of the NICU baby. J Perinatol 35(1):S5–S8PubMedPubMedCentralCrossRef

DAS-Taskforce, Baron R, Binder A et al. (2015) S3-Leitlinie Analgesie, Sedierung und Delirmanagement in der Intensivmedizin. Revision 2015 (DAS-Leitlinie 2015) – Kurzversion. GMS German Medical Science 13(Doc19)

Davies R (2004) New understandings of parental grief: Literature review. J Adv Nurs 46(5):506–513PubMedCrossRef

Eilertsen M-EB, Lövgren M, Wallin AE et al (2018) Cancer-bereaved siblings’ positive and negative memories and experiences of illness and death: A nationwide follow-up. Palliat Support Care 16(4):406–413PubMedCrossRef

Fernandes A, Campbell-Yeo M, Johnston CC (2011) Procedural pain management for neonates using nonpharmacological strategies: Part 1: sensorial interventions. Adv Neonatal Care 11(4):235–241PubMedCrossRef

Flaig F, Lotz JD, Knochel K et al (2019) Perinatal palliative care: a qualitative study evaluating the perspectives of pregnancy counselors. Palliat Med 33(6):704–711PubMedPubMedCentralCrossRef

Fraser LK, Miller M, Draper ES et al (2011) Place of death and palliative care following discharge from paediatric intensive care units. Arch Dis Child 96(12):1195–1198PubMedCrossRef

Garten L (2016) Perinatale Palliativversorgung: Warum es einer gesonderten Betrachtung bedarf. Paediatr Paedolog Austria 51(6):253–256CrossRef

Garten L, von der Hude K (2016) Palliativersorgung im Kreißsaal. Z Geburtshilfe Neonatol 220(2):53–57PubMedCrossRef

Garten L, Daehmlow S, Reindl T et al (2011) End-of-life opioid administration on neonatal and pediatric intensive care units: nurses’ attitudes and practice. Eur J Pain 15(9):958–965PubMedCrossRef

Garten L, Rösner B, Klapp C et al (2013) Familienzentrierte Sterbe- und individuelle Trauerbegleitung an einem Perinatalzentrum. Z Geburtshilfe Neonatol 217(3):95–102PubMedCrossRef

Garten L, Globisch M, von der Hude K et al (2018) Leitsätze für Palliativversorgung und Trauerbegleitung in der Peri-und Neonatologie, 1. Aufl. Bundesverband „Das frühgeborene Kind” e.V., Frankfurt am Main

Harlos MS, Stenekes S, Lambert D et al (2013) Intranasal fentanyl in the palliative care of newborns and infants. J Pain Symptom Manag 46(2):265–274CrossRef

Hellmann J, Knighton R, Lee SK et al (2016) Neonatal deaths: prospective exploration of the causes and process of end-of-life decisions. Arch Dis Child Fetal Neonatal Ed 101(2):F102–F1F7PubMedCrossRef

Horridge KA (2015) Advance care planning: practicalities, legalities, complexities and controversies. Arch Dis Child 100(4):380–385PubMedCrossRef

von der Hude K (2019) Grundlagen der Trauerbegleitung. In: Garten L, von der Hude K (Hrsg) Palliativversorgung und Trauerbegleitung in der Neonatologie. Springer, Berlin/Heidelberg

Kenner C, Press J, Ryan D (2015) Recommendations for palliative and bereavement care in the NICU: a family-centered integrative approach. J Perinatol 35(1):S19–S23PubMedPubMedCentralCrossRef

Kidszun A, Linebarger J, Walter JK et al (2016) What if the prenatal diagnosis of a lethal anomaly turns out to be wrong? Pediatrics 137(5):e20154514PubMedCrossRef

Kochanek KD, Murphy SL, Xu J (2015) Deaths: final data for 2011. Natl Vital Stat Rep 63(3):1–120PubMed

Kuhlen M, Höll JI, Sabir H et al (2016) Experiences in palliative home care of infants with life-limiting conditions. Eur J Pediatr 175(3):321–327PubMedCrossRef

Lammer K (2014) Erklärungen: Warum und worum wird getrauert? In: Trauer verstehen. Springer, Berlin/Heidelberg, S 31–70CrossRef

Lean RE, Rogers CE, Paul RA et al (2018) NICU hospitalization: long-term implications on parenting and child behaviors. Curr Treat Options Pediatr 4(1):49–69PubMedPubMedCentralCrossRef

Marc-Aurele KL, English NK (2017) Primary palliative care in neonatal intensive care. Semin Perinatol 41(2):133–9

Marsac ML, Kindler C, Weiss D et al (2018) Let’s talk about it: supporting family communication during end-of-life care of pediatric patients. J Palliat Med 21(6):862–878PubMedCrossRef

Marty CM, Carter BS (2018) Ethics and palliative care in the perinatal world. Semin Fetal Neonatal Med 23(1):35–38PubMedCrossRef

Michelson KN, Koogler T, Sullivan C et al (2009) Parental views on withdrawing life-sustaining therapies in critically ill children. Arch Pediatr Adolesc Med 163(11):986–992PubMedPubMedCentralCrossRef

Murphy A, O’Sullivan R, Wakai A et al (2014) Intranasal fentanyl for the management of acute pain in children. Cochrane Database Syst Rev 10:CD009942

Nolte-Buchholtz S, Garten L (2018) Perinatale Palliativversorgung - Betreuung von Neugeborenen mit lebensverkürzenden Erkrankungen und ihrer Familien. Monatsschr Kinderheilk 166(12):1127–1142CrossRef

October TW, Fisher KR, Feudtner C et al (2014) The parent perspective:“being a good parent” when making critical decisions in the PICU. Pediatr Crit Care Med 15(4):291–298PubMedPubMedCentralCrossRef

Parravicini E (2017) Neonatal palliative care. Curr Opin Pediatr 29(2):135–140PubMedCrossRef

Pector EA (2004) Views of bereaved multiple-birth parents on life support decisions, the dying process, and discussions surrounding death. J Perinatol 24(1):4–10PubMedCrossRef

Pillai Riddell RR, Racine NM, Gennis HG et al (2015) Non-pharmacological management of infant and young child procedural pain. Cochrane Database Syst Rev 12:CD006275

Rellensmann G, Hasan C (2009) Empfehlungen zum Vorgehen in Notfallsituationen. Monatsschr Kinderheilk 157:38–42CrossRef

Soni R, Vasudevan C, English S (2011) A national survey of neonatal palliative care in the UK. Infant 7(5):162–163

Stephens BE, Tucker R, Vohr BR (2010) Special health care needs of infants born at the limits of viability. Pediatrics 125(6):1152–1158PubMedCrossRef

Verhagen AE, Janvier A, Leuthner SR et al (2010) Categorizing neonatal deaths: a cross-cultural study in the United States, Canada, and the Netherlands. J Pediatr 156(1):33–37PubMedCrossRef

de Vos MA, Bos AP, Plötz FB et al (2015) Talking with parents about end-of-life decisions for their children. Pediatrics 135(2):e465–e476PubMedCrossRef

Vrakking AM, van der Heide A, Onwuteaka-Philipsen BD et al (2005) Medical end-of-life decisions made for neonates and infants in the Netherlands, 1995–2001. Lancet 365(9467):1329–1331PubMedCrossRef

Wool C, Catlin A (2019) Perinatal bereavement and palliative care offered throughout the healthcare system. Ann Palliat Med 8(Suppl 1):S22–SS9PubMedCrossRef

Youngblut JM, Brooten D (2013) Parents’ report of child’s response to sibling’s death in a neonatal or pediatric intensive care unit. Am J Crit Care 22(6):474–481PubMedCrossRef

Zernikow B (Hrsg) (2021) Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle. Springer, Berlin/Heidelberg

Ahuja N, Zhao W, Xiang H (2012) Medical errors in US pediatric inpatients with chronic conditions. Pediatrics 130(4):e786–ee93PubMedCrossRef

Aspesberro F, Mangione-Smith R, Zimmerman JJ (2015) Health-related quality of life following pediatric critical illness. Intensive Care Med 41(7):1235–1246PubMedCrossRef

Baker SC, Gledhill JA (2017) Systematic review of interventions to reduce psychiatric morbidity in parents and children after PICU admissions. Pediatr Crit Care Med 18(4):343–348PubMedCrossRef

Bellali T, Papadatou D (2006) Parental grief following the brain death of a child: does consent or refusal to organ donation affect their grief? Death Stud 30(10):883–917PubMedCrossRef

Brandt SA, Angstwurm H (2018) Bedeutung des irreversiblen Hirnfunktionsausfalls als sicheres Todeszeichen. Dtsch Ärztebl 115(41):675–681

Bundesärztekammer (2015) Richtlinie zur Feststellung des Hirntodes. Vierte Fortschreibung https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/irrev.Hirnfunktionsausfall.pdf. Zugegriffen am 08.06.2020

Burns JP, Sellers DE, Meyer EC et al (2014) Epidemiology of death in the pediatric intensive care unit at five US teaching hospitals. Crit Care Med 42(9):2101PubMedPubMedCentralCrossRef

Cox PN (2018) Death and dying 1987–2017: The destination is the same, the journey is different. Pediatr Crit Care Med 19(8S):S55–SS6PubMedCrossRef

Davidson JE, Jones C, Bienvenu OJ (2012) Family response to critical illness: Postintensive care syndrome–family. Crit Care Med 40(2):618–624PubMedCrossRef

Davydow DS, Richardson LP, Zatzick DF et al (2010) Psychiatric morbidity in pediatric critical illness survivors: a comprehensive review of the literature. Arch Pediatr Adolesc Med 164(4):377–385PubMedPubMedCentralCrossRef

Dechnik A, Traube C (2020) Delirium in hospitalised children. Lancet Child Adolesc Health 4(4):312–321PubMedCrossRef

Deutsche Stiftung Organtransplantation (2020). https://dso.de/. Zugegriffen am 17.05.2020

Deutscher Ethikrat (2015) Hirntod und Entscheidung zur Organspende. Stellungnahme. Deutscher Ethikrat, Berlin. https://www.ethikrat.org/fileadmin/Publikationen/Stellungnahmen/deutsch/stellungnahme-hirntod-und-entscheidung-zur-organspende.pdf. Zugegriffen am 11.06.2020

Devictor DJ, Latour JM, Group EIs (2011) Forgoing life support: how the decision is made in European pediatric intensive care units. Intensive Care Med 37(11):1881PubMedCrossRef

Dryden-Palmer K, Haut C, Murphy S et al (2018) Logistics of withdrawal of life-sustaining therapies in PICU. Pediatr Crit Care Med 19(8S):S19–S25PubMedCrossRef

Edwards JD, Houtrow AJ, Vasilevskis EE et al (2012) Chronic conditions among children admitted to US pediatric intensive care units: their prevalence and impact on risk for mortality and prolonged length of stay. Crit Care Med 40(7):2196–2203PubMedPubMedCentralCrossRef

Feudtner C, Feinstein JA, Zhong W et al (2014) Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr 14(1):199PubMedPubMedCentralCrossRef

Fraser LK, Parslow R (2018) Children with life-limiting conditions in paediatric intensive care units: a national cohort, data linkage study. Arch Dis Child 103(6):540–547PubMedCrossRef

Fraser LK, Miller M, Hain R et al (2012) Rising national prevalence of life-limiting conditions in children in england. Pediatrics 129(4):e923–e9e9PubMedCrossRef

Garstang J, Griffiths F, Sidebotham P (2014) What do bereaved parents want from professionals after the sudden death of their child: a systematic review of the literature. BMC Pediatr 14(1):269PubMedPubMedCentralCrossRef

van der Geest IM, Darlington A-SE, Streng IC et al (2014) Parents’ experiences of pediatric palliative care and the impact on long-term parental grief. J Pain Symptom Manag 47(6):1043–1053CrossRef

van der Geest IM, van den Heuvel-Eibrink MM, Falkenburg N et al (2015) Parents’ faith and hope during the pediatric palliative phase and the association with long-term parental adjustment. J Palliat Med 18(5):402–407PubMedCrossRef

Gilleland JC, Parshuram CS (2018) Discussing death as a possible outcome of PICU care. Pediatr Crit Care Med 19(8S):S4–S9PubMedCrossRef

Heneghan JA, Pollack MM (2017) Morbidity: changing the outcome paradigm for pediatric critical care. Pediatr Clin 64(5):1147–1165

van den Heuvel I, Nolte-Buchholtz S, Rellensmann G (2019) Pädiatrische Intensiv-und Palliativmedizin–unsere Patienten brauchen beides! Intensivmedizin up2date 15(01):91–110

Hill DL, Carroll KW, Dougherty S et al (2014) Point prevalence study of pediatric inpatients who are unable to communicate effectively about pain. Hosp Pediatr 4(6):382–386PubMedCrossRef

Kang TI, Hynson J (2018) Compassionate discharges from the PICU. Pediatr Crit Care Med 19(8S):S41–SS7PubMedCrossRef

Koch KD, Jones BL (2018) Supporting parent caregivers of children with life-limiting illness. Children (Basel, Switzerland) 5(7)

Kreicbergs U, Valdimarsdottir U, Onelöv E et al (2004) Talking about death with children who have severe malignant disease. N Engl J Med 351(12):1175–1186PubMedCrossRef

LaFond CM, Hanrahan KS, Pierce NL et al (2019) Pain in the pediatric intensive care unit: How and what are we doing? Am J Crit Care 28(4):265–273PubMedCrossRef

Lopes-Júnior LC, Rosa MAdRd, Lima RAGd (2018) Psychological and psychiatric outcomes following PICU admission: a systematic review of cohort studies. Pediatr Crit Care Med 19(1):e58–e67

Luberda K, Cleaver K (2017) How modifiable factors influence parental decision-making about organ donation. Nurs Child Young People 29(9):29PubMedCrossRef

Marsac ML, Kindler C, Weiss D et al (2018) Let’s talk about it: supporting family communication during end-of-life care of pediatric patients. J Palliat Med 21(6):862–78

McAlvin SS, Carew-Lyons A (2014) Family presence during resuscitation and invasive procedures in pediatric critical care: a systematic review. Am J Crit Care 23(6):477–485PubMedCrossRef

Meert KL, Donaldson A, Nadkarni V et al (2009) Multicenter cohort study of in-hospital pediatric cardiac arrest. Pediatr Crit Care Med 10(5):544–553PubMedPubMedCentralCrossRef

Meert KL, Donaldson AE, Newth CJ et al (2010) Complicated grief and associated risk factors among parents following a child’s death in the pediatric intensive care unit. Arch Pediatr Adolesc Med 164(11):1045–1051PubMedPubMedCentralCrossRef

Meert KL, Shear K, Newth CJL et al (2011) Follow-up study of complicated grief among parents eighteen months after a child’s death in the pediatric intensive care unit. J Palliat Med 14(2):207–214PubMedPubMedCentralCrossRef

Meyer EC, Ritholz MD, Burns JP et al (2006) Improving the quality of end-of-life care in the pediatric intensive care unit: parents’ priorities and recommendations. Pediatrics 117(3):649–657PubMedCrossRef

Morris S, Fletcher K, Goldstein R (2019) The grief of parents after the death of a young child. J Clin Psychol Med Settings 26(3):321–338PubMedCrossRef

Nakagawa TA, Shemie SD, Dryden-Palmer K et al (2018) Organ donation following neurologic and circulatory determination of death. Pediatr Crit Care Med 19(8S):S26–S32PubMedCrossRef

Nyborn JA, Olcese M, Nickerson T et al (2016) „Don’t try to cover the sky with your hands“: parents’ experiences with prognosis communication about their children with advanced cancer. J Palliat Med 19(6):626–631PubMedCrossRef

October T, Dryden-Palmer K, Copnell B et al (2018) Caring for parents after the death of a child. Pediatr Crit Care Med 19(8):S61

Peeler K, Wolfe J (2018) Pediatric unexpected death: examination of a unique population and its end-of-life care management (S741). J Pain Symptom Manag 55(2):679CrossRef

Pinto NP, Rhinesmith EW, Kim TY et al (2017) Long-term function after pediatric critical illness: results from the survivor outcomes study. Pediatr Crit Care Med 18(3):e122–ee30PubMedCrossRef

Pollack MM, Holubkov R, Funai T et al (2015) Simultaneous prediction of new morbidity, mortality, and survival without new morbidity from pediatric intensive care: a new paradigm for outcomes assessment. Crit Care Med 43(8):1699PubMedPubMedCentralCrossRef

Puntillo K, Nelson JE, Weissman D et al (2014) Palliative care in the ICU: relief of pain, dyspnea, and thirst – a report from the IPAL-ICU Advisory Board. Intensive Care Med 40(2):235–248PubMedCrossRef

Rellensmann G, Laumann K, Gillner J et al (2014) Anwesenheit der Eltern bei Notfallsituationen in der Pädiatrie. Monatsschr Kinderheilk 162(1):70–74CrossRef

Rennick JE, St-Sauveur I, Knox AM et al (2019) Exploring the experiences of parent caregivers of children with chronic medical complexity during pediatric intensive care unit hospitalization: an interpretive descriptive study. BMC Pediatr 19(1):272PubMedPubMedCentralCrossRef

Rosenberg AR, Wolfe J, Wiener L et al (2016) Ethics, emotions, and the skills of talking about progressing disease with terminally ill adolescents: a review. JAMA Pediatr 170(12):1216–1223PubMedPubMedCentralCrossRef

Schöne-Seifert B (2014) Hirntod: Ja aber⋯. In: Ach JS, Lüttenberg B, Quante M (Hrsg) wissen · leben · ethik Themen und Positionen der Bioethik. Mentis, Münster, S 67–77

Schöne-Seifert B, Prien T, Rellensmann G et al (2011) Medizinethik: Behandlung potenzieller Organspender im Präfinalstadium. Dtsch Arztebl 108(40):A 2080/B-1770/C-53

Shewmon DA (2009) Brain death: can it be resuscitated? Hast Cent Rep 39(2):18–24CrossRef

Sidgwick P, Fraser J, Fortune P-M et al (2019) Parallel planning and the paediatric critical care patient. Arch Dis Child 104:994–997PubMedCrossRef

Silver GH, Kearney JA, Bora S et al (2019) A clinical pathway to standardize care of children with delirium in pediatric inpatient settings. Hosp Pediatr 9(11):909–916PubMedCrossRef

Sisk BA, Mack JW, Ashworth R et al (2018) Communication in pediatric oncology: state of the field and research agenda. Pediatr Blood Cancer 65(1):e26727CrossRef

Stoecker R (2014) Zwischen Leben und Tod. In: Ach JS, Lüttenberg B, Quante M (eds) wissen · leben · ethik. Themen und Positionen der Bioethik. Mentis, Münster, S 79–90

Traube C, Silver G, Reeder RW et al (2017) Pediatric delirium in critically-ill children: an international point prevalence study. Crit Care Med 45(4):584PubMedPubMedCentralCrossRef

Trowbridge A, Walter JK, McConathey E et al (2018) Modes of death within a children’s hospital. Pediatrics 142(4):e20174182

Weiss A, Fortinsky R, Laughlin J et al (1997) Parental consent for pediatric cadaveric organ donation. Transplant Proc 29(3):1896–1901PubMedCrossRef

Yagiela LM, Carlton EF, Meert KL et al (2019) Parent medical traumatic stress and associated family outcomes after pediatric critical illness: A systematic review. Pediatr Crit Care Med 20(8):759–768PubMedCrossRef

Youngblut JM, Brooten D, Cantwell GP et al (2013) Parent health and functioning 13 months after infant or child NICU/PICU death. Pediatrics 132(5):e1295–ee301PubMedPubMedCentralCrossRef

Allen J, Molloy E, McDonald D (2020) Severe neurological impairment: a review of the definition. Dev Med Child Neurol 62(3):277–282PubMedCrossRef

Andrews JG, Wahl RA (2018) Duchenne and Becker muscular dystrophy in adolescents: current perspectives. Adolesc Health Med Ther 9:53PubMedPubMedCentral

Biermann A, Goetze H (2005) Sonderpädagogik. Eine Einführung. Kohlhammer, Stuttgart

Borchert J (2007) Einführung in die Sonderpädagogik. Oldenbourg Wissenschaftsverlag, MünchenCrossRef

Braun U (1996) Unterstützte Kommunikation. Selbst bestimmmtes Leben, Düsseldorf

Breau LM, Camfield CS, McGrath PJ et al (2003) The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med 157(12):1219–1226PubMedCrossRef

Brown A, Clark JD (2015) A parent’s journey: incorporating principles of palliative care into practice for children with chronic neurologic diseases. Semin Pediatr Neurol 22(3):159–165PubMedCrossRef

Chiriboga CA (2017) Nusinersen for the treatment of spinal muscular atrophy. Expert Rev Neurother 17(10):955–962PubMedCrossRef

De Vivo DC, Bertini E, Swoboda KJ et al (2019) Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study. Neuromuscul Disord 29(11):842–856PubMedPubMedCentralCrossRef

DIMDI (2004) CF – Internationale Klassifikation der Funktionsfähigkeit, Behinderung und Gesundheit. http://www.dimdi.de/static/de/klassi/icf/index.htm. Zugegriffen am 11.06.2020

DIMDI (2011) ICF-CY: Internationale Klassifikation der Funktionsfähigkeit, Behinderung und Gesundheit bei Kindern und Jugendlichen. Huber, Bern

Drake R, Frost J, Collins JJ (2003) The symptoms of dying children. J Pain Symptom Manag 26(1):594–603CrossRef

Droege M, Sproule D, Arjunji R et al (2020) Economic burden of spinal muscular atrophy in the United States: a contemporary assessment. J Med Econ 23(1):70–79PubMedCrossRef

Duque JAP, Ferreira CF, Zachia SA et al (2019) The natural history of pregnancies with prenatal diagnosis of Trisomy 18 or Trisomy 13: Retrospective cases of a 23-year experience in a Brazilian public hospital. Genet Mol Biol 42(1):286–296PubMedPubMedCentralCrossRef

Faulkner KW, Thayer PB, Coulter DL (2005) Neurological and neuromuscular symptoms. In: Goldman A, Hain R, Liben S (Hrsg) Oxford textbook of palliative care for children. Oxford University Press, Oxford

Finkel RS, Mercuri E, Darras BT et al (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377:1723–1732PubMedCrossRef

Fornefeld B (2008) Menschen mit Komplexer Behinderung. Selbstverständnis und Aufgaben der Behindertenpädagogik. Reinhardt, München

Fröhlich A, Simon A (2004) Gemeinsamkeiten entdecken. Verlag selbstbestimmtes Leben, Düsseldorf

Hedderich I (2006) Unterstütze Kommunikation in der Frühförderung: Grundlagen - Diagnostik - Beispiele. Klinkhardt, Bad Heilbrunn

Hoy SM (2019) Onasemnogene abeparvovec: first global approval. Drugs 79(11):1255–1262PubMedCrossRef

Hunt A, Burne R (1995) Medical and nursing problems of children with neurodegenerative disease. Palliat Med 9(1):19PubMedCrossRef

Janvier A, Farlow B, Wilfond BS (2012) The Experience of Families With Children With Trisomy 13 and 18 in Social Networks. Pediatrics 130(2):293–298PubMedCrossRef

Janvier A, Farlow B, Barrington KJ (2016) Parental hopes, interventions, and survival of neonates with trisomy 13 and trisomy 18. Am J Med Genet C: Semin Med Genet 172(3):279–287CrossRef

Kim J-K, Jha NN, Feng Z et al (2020) Muscle-specific SMN reduction reveals motor neuron–independent disease in spinal muscular atrophy models. J Clin Invest 130(3):1271–1287PubMedPubMedCentralCrossRef

Leuthner SR, Acharya K (2020) Perinatal counseling following a diagnosis of trisomy 13 or 18: incorporating the facts, parental values, and maintaining choices. Adv Neonatal Care 20(3):204–215PubMedCrossRef

Malcolm C, Hain R, Gibson F et al (2012) Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families. Acta Paediatr 101(9):985–992PubMedCrossRef

Mar H, Sall N (1999) Dimensions of communication. Part I: Developing a communication profile [and] part II: designing an intervention plan. An instrument to assess the communication skills and behaviors of individuals with disabilities. New York. https://documents.nationaldb.org/products/dimensions-of-communication.pdf. Zugegriffen am 11.06.2020

McDonald CM, Sajeev G, Yao Z et al (2020) Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials. Muscle Nerve 61(1):26–35PubMedCrossRef

Meyer RE, Liu G, Gilboa SM et al (2016) Survival of children with trisomy 13 and trisomy 18: A multi-state population-based study. Am J Med Genet A 170(4):825–837CrossRef

Neubauer K, Boss RD (2020) Ethical considerations for cardiac surgical interventions in children with trisomy 13 and trisomy 18. Am J Med Genet C: Semin Med Genet 184(1):187–191CrossRef

Pechmann A, Baumann M, Bernert G et al (2020) Treatment with nusinersen–challenges regarding the indication for children with SMA Type 1. J Neuromuscul Dis 7(1):41–46PubMedCrossRef

Peterson R, Calamur N, Fiore A et al (2018) Factors influencing outcomes after cardiac intervention in infants with trisomy 13 and 18. Pediatr Cardiol 39(1):140–147PubMedCrossRef

Polido GJ, Miranda MMVd, Carvas Junior N et al (2019) Cognitive performance of children with spinal muscular atrophy: a systematic review. Dement Neuropsychol 13(4):436–443

Sansone VA, Pirola A, Albamonte E et al (2020) Respiratory needs in patients with type 1 spinal muscular atrophy treated with nusinersen. J Pediatr 219:223-8.e4

Schlack HG, Thyen U, von Kries R (2009) Sozialpädiatrie. Gesundheitswissenschaft und pädiatrischer Alltag. Springer, Heidelberg

Schmidt-Ohlemann M (2005) Mehrfachbehinderungen bei Kindern und Jugendlichen. In: Bundesarbeitsgemeinschaft für Rehabilitation (Hrsg) Rehabilitation und Teilhabe. Wegweiser für Ärzte und andere Fachkräfte der Rehabilitation. Deutscher Ärzteverlag, Köln

Schuntermann MF (2009) Einführung in die ICF (Grundkurs - Übungen - offene Fragen). ecomed MEDIZIN, Hamburg

Shorrock HK, Gillingwater TH, Groen EJ (2018) Overview of current drugs and molecules in development for spinal muscular atrophy therapy. Drugs 78(3):293–305PubMedPubMedCentralCrossRef

Speck O, Thalhammer M (1974) Die Rehabilitation der Geistigbehinderten - Ein Beitrag zur sozialen Integration. Ernst Reinhardt, München/Basel

Tietze AL, Blankenburg M, Hechler T et al (2012) Sleep disturbances in children with multiple disabilities. Sleep Med Rev 16(2):117–127PubMedCrossRef

Vill K, Kölbel H, Schwartz O et al (2019) One year of newborn screening for SMA–Results of a German pilot project. J Neuromuscul Dis 6(4):503–515PubMedPubMedCentralCrossRef

Wadman RI, van der Pol WL, Bosboom WMJ et al (2019) Drug treatment for spinal muscular atrophy type I. Cochrane Database Syst Rev(12):CD006281.pub5

Wadman RI, van der Pol WL, Bosboom WM et al (2020) Drug treatment for spinal muscular atrophy types II and III. Cochrane Database Syst Rev 1:CD006282PubMed

World Health Organization (WHO) (2001) International classification of functioning, disability and health (ICF). WHO, Genf

Zernikow B (2007) Palliativmedizin bei genetischen Erkrankungen der Kindheit. In: Nauck F, Radbruch L, Aulbert E (Hrsg) Lehrbuch der Palliativmedizin. Schattauer, Stuttgart/New York

Zernikow B (Hrsg) (2021) Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle. Springer, Berlin/Heidelberg

Andres AM, Thompson J, Grant W et al (2008) Repeat surgical bowel lengthening with the STEP procedure. Transplantation 85(9):1294–1299PubMedCrossRef

Beath SV, Davies P, Papadopoulou A et al (1996) Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 31(4):604–606PubMedCrossRef

Blaszyk H, Wild PJ, Oliveira A et al (2005) Hepatic copper in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol 39(4):318–320PubMedCrossRef

Bongaerts G, Bakkeren J, Severijnen R et al (2000) Lactobacilli and acidosis in children with short small bowel. J Pediatr Gastroenterol Nutr 30(3):288–293PubMedCrossRef

Buchman AL, Fryer J, Wallin A et al (2006) Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. JPEN J Parenter Enteral Nutr 30(6):487–491PubMedCrossRef

Carter BA, Cohran VC, Cole CR et al (2017) Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome. J Pediatr 181:102–111PubMedCrossRef

Cavicchi M, Beau P, Crenn P et al (2000) Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 132(7):525–532PubMedCrossRef

Christensen RD, Henry E, Wiedmeier SE et al (2007) Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol 27(5):284–290PubMedCrossRef

Clayton PT, Whitfield P, Iyer K (1998) The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 14(1):158–164PubMedCrossRef

Cooper A, Floyd TF, Ross AJ et al (1984) Morbidity and mortality of short-bowel syndrome acquired in infancy: an update. J Pediatr Surg 19(6):711–718PubMedCrossRef

Duro D, Kamin D, Duggan C (2008) Overview of pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 47:S33–SS6PubMedCrossRef

European Society of Paediatric Gastroenterology and Nutrition (ESPGHAN) (2018) ESPGHAN guidelines. https://www.espghan.info. Zugegriffen am 21.02.2020

Gawecka A, Michalkiewicz J, Kornacka MK et al (2008) Immunologic properties differ in preterm infants fed olive oil vs soy-based lipid emulsions during parenteral nutrition. JPEN J Parenter Enteral Nutr 32(4):448–453PubMedCrossRef

Goulet O, Colomb-Jung V, Joly F (2009) Role of the colon in short bowel syndrome and intestinal transplantation. J Pediatr Gastroenterol Nutr 48(Suppl 2):S66–S71PubMedCrossRef

Greenberg RG, Moran C, Ulshen M et al (2010) Outcomes of catheter-associated infections in pediatric patients with short bowel syndrome. J Pediatr Gastroenterol Nutr 50(4):460–462PubMedPubMedCentralCrossRef

Guertin F, Roy CC, Lepage G et al (1991) Effect of taurine on total parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 15(3):247–251PubMedCrossRef

Gura KM, Elisofon SA (2012) Parenteral nutrition-associated liver disease in infants. UpToDate Inc. (Hrsg). http://www.uptodate.com/contents/parenteral-nutrition-associated-liver-disease-in-infants. Zugegriffen am 04.02.2020

Halperin ML, Kamel KS (1996) D-lactic acidosis: turning sugar into acids in the gastrointestinal tract. Kidney Int 49(1):1–8PubMedCrossRef

Hyman PE, Everett SL, Harada T (1986) Gastric acid hypersecretion in short bowel syndrome in infants: Association with extent of resection and enteral feeding. J Pediatr Gastroenterol Nutr 5(2):191–197PubMedCrossRef

Jeppesen PB, Staun M, Tjellesen L et al (1998) Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 43(6):763–769PubMedPubMedCentralCrossRef

Jeppesen PB, Pertkiewicz M, Messing B et al (2012) Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 143(6):1473–1481PubMedCrossRef

Kaufman SS, Loseke CA, Lupo JV et al (1997) Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr 131(3):356–361PubMedCrossRef

King DR, Komer M, Hoffman J et al (1985) Broviac catheter sepsis: the natural history of an iatrogenic infection. J Pediatr Surg 20(6):728–733PubMedCrossRef

Klein GL, Goldblum RM, Moslen MT et al (1993) Increased biliary transferrin excretion following parenteral aluminum administration to rats. Pharmacol Toxicol 72(4-5):373–376PubMedCrossRef

Ladefoged K, Christensen KC, Hegnhöj J et al (1989) Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut 30(7):943–949PubMedPubMedCentralCrossRef

Mager DR, Marcon M, Wales P et al (2008) Use of N-acetyl cysteine for the treatment of parenteral nutrition-induced liver disease in children receiving home parenteral nutrition. J Pediatr Gastroenterol Nutr 46(2):220–223PubMedCrossRef

McDoniel K, Taylor B, Huey W et al. (2004) Use of clonidine to decrease intestinal fluid losses in patients with high-output short-bowel syndrome. JPEN J Parenter Enteral Nutr 28(4):265–268

McMillan NB, Mulroy C, MacKay MW et al (2008) Correlation of cholestasis with serum copper and whole-blood manganese levels in pediatric patients. Nutr Clin Pract 23(2):161–165PubMedCrossRef

Nightingale JMD, Lennard-Jones JE, Walker ER et al (1990) Jejunal efflux in short bowel syndrome. Lancet 336(8718):765–768PubMedCrossRef

Obialo CI, Clayman RV, Matts JP et al (1991) Pathogenesis of nephrolithiasis post-partial ileal bypass surgery: case-control study. The POSCH Group. Kidney Int 39(6):1249–1254PubMedCrossRef

Ordonez P, Sondheimer JM, Fidanza S et al (2006) Long-term outcome of a patient with congenital short bowel syndrome. J Pediatr Gastroenterol Nutr 42(5):576–580PubMedCrossRef

Pauley-Hunter RJ, Vanderhoof JA (2012) Pathophysiology of the short bowel syndrome. Uptodate Inc. (Hrsg). http://www.uptodate.com/contents/pathophysiology-of-the-short-bowel-syndrome. Zugegriffen am 04.02.2020

Posovszky C, Ballauff A, Busch A et al (2019) Positionspapier Tedeglutide. Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE) (Hrsg). https://static1.squarespace.com/static/55db8048e4b089b9924893b3/t/5aa7d0f1c83025af3fd1a8df/1520947443695/1803_Positionspapier_GPGE_Teduglutid_Konsens.pdf. Zugegriffen am 11.06.2020

Schmidt-Sommerfeld E, Snyder G, Rossi TM et al (1990) Catheter-related complications in 35 children and adolescents with gastrointestinal disease on home parenteral nutrition. JPEN J Parenter Enteral Nutr 14(2):148–151PubMedCrossRef

Sondheimer JM, Asturias E, Cadnapaphornchai M (1998) Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 27(2):131–137PubMedCrossRef

Thompson JS, Ferguson DC (2000) Effect of the distal remnant on ileal adaptation. J Gastrointest Surg 4(4):430–434PubMedCrossRef

Thompson JS, Vanderhoof JA, Antonson DL (1985) Intestinal tapering and lengthening for short bowel syndrome. J Pediatr Gastroenterol Nutr 4(3):495–497PubMedCrossRef

Vanderhoof JA, Pauley-Hunter RJ (2012) Chronic complications of the short bowel syndrome in children. http://www.uptodate.com/contents/chronic-complications-of-the-short-bowel-syndrome-in-children. Zugegriffen am 11.06.2020

Vanderhoof JA, Langnas AN, Pinch LW et al (1992) Short bowel syndrome. J Pediatr Gastroenterol Nutr 14(4):359–370PubMedCrossRef

Vanderhoof JA, Young RJ, Murray N et al (1998) Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 27(2):155–160PubMedCrossRef

Vanderhoof JA, Jensen C, Hoppin A (2012) Management of the short bowel syndrome. Uptodate Inc. (Hrsg). http://www.uptodate.com/contents/management-of-the-short-bowel-syndrome-in-children. Zugegriffen am 04.02.2020

Williams HE (1978) Oxalic acid and the hyperoxaluric syndromes. Kidney Int 13(5):410–417PubMedCrossRef

Zaman N, Tam YK, Jewell LD et al (1996) Effects of taurine supplementation in parenteral nutrition-associated hepatosteatosis and lidocaine metabolism. A study using isolated rat liver perfusion. Drug Metab Dispos 24(5):534–541PubMed

European Society of Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN). https://www.espghan.info

Gesellschaft für Pädiatrische Gastroenterologie und Ernährung e. V. (GPGE). https://www.gpge.eu

Baker JN, Harper JA, Kane JR et al (2011) Implementation and Evaluation of an Automated Patient Death Notification Policy at a Tertiary Pediatric Oncology Referral Center. J Pain Symptom Manag 42(5):652–656CrossRef

Beretta S, Polastri D, Clerici CA et al (2010) End of life in children with cancer: Experience at the Pediatric Oncology Departement of the Istituto Nazionale in Milan. Pediatr Blood Cancer 54(1):88–91PubMedCrossRef

Bluebond-Langner M, Belasco JB, Goldman A et al (2007) Understanding parents’ approaches to care and treatment children with cancer when standard therapy has failed. J Clin Oncol 25(17):2414–2419PubMedCrossRef

Bradshaw G, Hinds P, Lensing S et al (2005) Cancer-related deaths in children and adolescents. J Palliat Med 8(1):86–95PubMedCrossRef

Changa AR, Czeisler BM, Lord AS (2019) Management of elevated intracranial pressure: a review. Curr Neurol Neurosci Rep 19(12):99PubMedCrossRef

Collins JJ, Byrnes ME, Dunkel IJ et al (2000) The measurement of symptoms in children with cancer. J Pain Symptom Manag 19(5):363–377CrossRef

Delgado E, Barfield RC, Baker JN et al (2010) Availability of palliative care services for children with cancer in economically diverse regions of the world. Eur J Cancer 46(12):2260–2266PubMedPubMedCentralCrossRef

Desforges JF, Byrne TN (1992) Spinal cord compression from epidural metastases. N Engl J Med 327(9):614–619CrossRef

Dussel V, Joffe S, Hilden JM et al (2010) Considerations about hastening death among parents of children who die of cancer. Arch Pediatr Adolesc Med 164(3):231–237PubMedPubMedCentralCrossRef

Esquenazi Y, Lo VP, Lee K (2017) Critical care management of cerebral edema in brain tumors. J Intensive Care Med 32(1):15–24PubMedCrossRef

Frühwald M (2006) ZNS-Tumoren im Kindes-und Jugendalter: Diagnostik, Therapiemöglichkeiten und palliative Ansätze. Kinder- Jugendarzt 37:633–645

Frühwald MC, Rutkowski S (2011) Tumors of the central nervous system in children and adolescents. Dtsch Arztebl Int 108(22):390–397PubMedPubMedCentral

Frühwald MC, Holzapfel J, Hasselblatt M (2019) Tumoren des ZNS im Kindes-und Jugendalter–Grundlagen und aktuelle Entwicklungen. Trilium Krebsmedizin 28(1):32–43

Goldman A (1996) Home care of dying children. J Palliat Care 12(3):16–19PubMedCrossRef

Goldman A, Hewitt M, Collins GS et al (2006) Symptoms in children/young people with progressive malignant disease: United Kingdom children’s cancer study group/paediatric oncology nurses forum survey. Pediatrics 117(6):e1179–e1e86PubMedCrossRef

Goodenough B, Drew B, Higgins S et al (2004) Bereavement outcomes for parents who lose a child to cancer: Are place of death and sex of parent associated with differences in psychological functioning? Psychooncology 13(11):779–791PubMedCrossRef

Hechler T, Blankenburg M, Friedrichsdorf S et al (2008) Parents’ perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer. Klin Padiatr 220(3):166–174PubMedCrossRef

Hunt H, Valdimarsdottir U, Mucci L et al (2006) When death appears best for the child with severe malignancy: A nationwide parental follow-up. Palliat Med 20(6):567–577PubMedCrossRef

Hynson JL, Sawyer SM (2001) Paediatric palliative care: distinctive needs and emerging issues. J Paediatr Child Health 37(4):323–325PubMedCrossRef

Jalmsell L, Kreicbergs U, Onelöv E et al (2006) Symptoms affecting children with malignancies during the last month of life: A nationwide follow-up. Pediatrics 117(4):1314–1320PubMedCrossRef

Janssen G, Friedland C, Richter U et al (2004) Ambulante palliativmedizinische Versorgung krebskranker Kinder und ihrer Familien [Out-patient palliative care of children with cancer and their families]. Klin Padiatr 216(3):183–188PubMedCrossRef

Kaal EC, Vecht CJ (2004) The management of brain edema in brain tumors. Curr Opin Oncol 16(6):593–600PubMedCrossRef

Kars MC, Grypdonck MHF, Beishuizen A et al (2010) Factors influencing parental readiness to let their child with cancer die. Pediatr Blood Cancer 54(7):1000–1008PubMedCrossRef

Kaye EC, Jerkins J, Gushue CA et al (2018) Predictors of late palliative care referral in children with cancer. J Pain Symptom Manag 55(6):1550–1556CrossRef

Kleihues P, Louis DN, Scheithauer BW et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61(3):215–225PubMedCrossRef

Klopfenstein KJ, Hutchison C, Clark C et al (2001) Variables influencing end-of-life care in children and adolescents with cancer. J Pediatr Hematol Oncol 23(8):481–486PubMedCrossRef

Kreicbergs U (2006) Parental experiences of losing a child to cancer: A nationwide survey. Psychother Austr 12(1):12–19

Kreicbergs U, Valdimarsdottir U, Onelöv E et al (2004a) Anxiety and depression in parents 4-9 years after the loss of a child owing to malignancy: A population-based follow-up. Psychol Med 34(8):1431–1441PubMedCrossRef

Kreicbergs U, Valdimarsdottir U, Onelöv E et al (2004b) Talking about death with children who have severe malignant disease. N Engl J Med 351(12):1175–1186PubMedCrossRef

Kreicbergs U, Valdimarsdottir U, Steineck G et al (2004c) A population-based nationwide study of parents’ perceptions of a questionnaire on their child’s death due to cancer. Lancet 364(9436):787–789PubMedCrossRef

Kreicbergs U, Valdimarsdottir U, Onelöv E et al (2005) Care-related distress. A nationwide study of parents who lost their child to cancer. J Clin Oncol 23(36):9162–9171PubMedCrossRef

Kreicbergs U, Lannen P, Onelöv E et al (2007) Parental grief after losing a child to cancer: Impact of professional and social support on long-term outcomes. J Clin Oncol 25(22):3307–3312PubMedCrossRef

Lin AL, Avila EK (2017) Neurologic emergencies in the patients with cancer: diagnosis and management. J Intensive Care Med 32(2):99–115PubMedCrossRef

Loghin M, Levin VA (2006) Headache related to brain tumors. Curr Treat Options Neurol 8(1):21–32PubMedCrossRef

Mack JW, Hilden JM, Watterson J et al (2005) Parent and physician perspectives on quality of care at the end of life in children with cancer. J Clin Oncol 23(36):9155–9161PubMedCrossRef

Mack JW, Cronin AM, Uno H et al (2019) Unrealistic parental expectations for cure in poor-prognosis childhood cancer. Cancer 126:416–424PubMedCrossRef

Marcus KL, Santos G, Ciapponi A et al (2020) Impact of specialized pediatric palliative care: a systematic review. J Pain Symptom Manage 59(2):339-64.e10

McCallum DE, Byrne P, Bruera E (2000) How children die in hospital. J Pain Symptom Manag 20(6):417–423CrossRef

Roth C, Stitz H, Roth C et al (2016) Craniocervical manual lymphatic drainage and its impact on intracranial pressure–a pilot study. Eur J Neurol 23(9):1441–1446PubMedCrossRef

Ryken TC, McDermott M, Robinson PD et al (2010) The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neuro-Oncol 96(1):103–114CrossRef

Ryken TC, Kuo JS, Prabhu RS et al (2019) Congress of neurological surgeons systematic review and evidence-based guidelines on the role of steroids in the treatment of adults with metastatic brain tumors. Neurosurgery 84(3):E190–E191CrossRef

Shah S, Weitman S, Langevin AM et al (1998) Phase I therapy trials in children with cancer. J Pediatr Hematol Oncol 20(5):431–438PubMedCrossRef

Sirkiä K, Saarinen UM, Ahlgren B et al (1997) Terminal care of the child with cancer at home. Acta Paediatr 86(10):1125–1130PubMedCrossRef

Sisk BA, Kang TI, Goldstein R et al (2019) Decisional burden among parents of children with cancer. Cancer 125(8):1365–1372PubMedCrossRef

Snaman J, McCarthy S, Wiener L et al (2020) Pediatric palliative care in oncology. J Clin Oncol 38(9):954–962PubMedPubMedCentralCrossRef

Snaman JM, Kaye EC, Baker JN et al (2018) Pediatric palliative oncology: the state of the science and art of caring for children with cancer. Curr Opin Pediatr 30(1):40–48PubMedCrossRef

Streffer J, Bitzer M, Schabet M et al (2001) Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15. Neurology 56(9):1219–1221PubMedCrossRef

Surkan PJ, Dickman PW, Steineck G et al (2006a) Home care of a child dying of malignancy and parental awareness of a child’s impending death. Palliat Med 20:161–169PubMedCrossRef

Surkan PJ, Kreicbergs U, Valdimarsdottir U et al (2006b) Perceptions of inadequate health care and feelings of guilt in parents after the death of a child to a malignancy: a population-based long-term follow-up. J Palliat Med 9(2):317–331PubMedCrossRef

Udaka YT, Packer RJ (2018) Pediatric brain tumors. Neurol Clin 36(3):533–556PubMedCrossRef

Ullrich CK, Dussel V, Hilden JM et al (2010) End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care. Blood 115(19):3879–3885PubMedCrossRef

Valdimarsdóttir U, Kreicbergs U, Hauksdóttir A et al (2007) Parents’ intellectual and emotional awareness of their child’s impending death to cancer: a population-based long-term follow-up study. Lancet Oncol 8(8):706–714PubMedCrossRef

Vallero SG, Lijoi S, Bertin D et al (2014) End-of-life care in pediatric neuro-oncology. Pediatr Blood Cancer 61(11):2004–2011PubMedCrossRef

Vickers JL, Carlise C (2000) Choices and control: parental experiences in pediatric terminal home care. J Pediatr Oncol Nurs 17(1):12–21PubMedCrossRef

Watterson G, Goldman A, Michalski A (2002) Corticosteroids in the palliative phase of paediatric brain tumours. Arch Dis Child 86(Suppl 1):A76

Wick W, Küker W (2004) Brain edema in neurooncology: radiological assessment and management. Oncol Res Treat 27(3):261–266CrossRef

Widger K, Sutradhar R, Rapoport A et al (2018) Predictors of specialized pediatric palliative care involvement and impact on patterns of end-of-life care in children with cancer. J Clin Oncol 36(8):801–807PubMedCrossRef

Wilne SH, Ferris RC, Nathwani A et al (2006) The presenting features of brain tumours: a review of 200 cases. Arch Dis Child 91(6):502–506PubMedPubMedCentralCrossRef

Wolfe J, Grier HE, Klar N et al (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342(5):326–333PubMedCrossRef

Zernikow B (Hrsg) (2021) Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle. Springer, Berlin/Heidelberg

Zernikow B, Szybalski K, Hübner-Mohler B et al (2019) Specialized pediatric palliative care services for children dying from cancer: A repeated cohort study on the developments of symptom management and quality of care over a 10-year period. Palliat Med 33(3):381–391PubMedCrossRef

Ezeanolue EE, Wodi AP, Patel R et al (2006) Sexual behaviors and procreational intentions of adolescents and young adults with perinatally acquired human immunodeficiency virus infection: experience of an urban tertiary center. J Adolesc Health 38(6):719–725PubMedCrossRef

Garvie PA, Zeldow B, Malee K et al (2014) Discordance of cognitive and academic achievement outcomes in youth with perinatal HIV exposure. Pediatr Infect Dis J 33(9):e232PubMedPubMedCentralCrossRef

Gaughan DM, Hughes MD, Oleske JM et al (2004) Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. Pediatrics 113(6):e544–ee51PubMedCrossRef

Howland LC, Storm DS (2007) Negative life events: risk to health- related quality of life in children and youth with HIV infection. J Assoc Nurses AIDS Care 18:3–11PubMedCrossRef

Lee GM, Gortmaker SL, McIntosh K et al (2006) Quality of life for children and adolescents: Impact of HIV infection and antiretroviral treatment. Pediatrics 117(2):273–283PubMedCrossRef

Oleske JM, Czarniecki L (1999) Continuum of palliative care: lessons from caring for children infected with HIV-1. Lancet 345:1287–1291CrossRef

Wilmshurst JM, Hammond CK, Donald K et al (2018) NeuroAIDS in children. In: Brew BJ (Hrsg) Handbook of clinical neurology. Elsevier, Amsterdam/New York, S 99–116

https://www.cdc.gov/mmwr/preview/mmwrhtml/00032890.htm. Abgerufen 06.01.2020

https://www.hivbuch.de. Abgerufen 06.01.2020

https://www.rki.de. Abgerufen 06.01.2020

Balkin EM, Sleeper LA, Kirkpatrick JN et al (2018) Physician perspectives on palliative care for children with advanced heart disease: a comparison between pediatric cardiology and palliative care physicians. J Palliat Med

Barnea O, Austin EH, Richman B et al (1994) Balancing the circulation: theoretic optimization of pulmonary/systemic flow ratio in hypoplastic left heart syndrome. J Am Coll Cardiol 24(5):1376–1381PubMedCrossRef

Berger J, Gartner J (2006) X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochimica et Biophysica Acta (BBA)-Molecular Cell Res 1763(12):1721–1732CrossRef

Buchhorn R, Hulpke-Wette M, Ruschewski W et al (2003) Effects of therapeutic beta blockade on myocardial function and cardiac remodelling in congenital cardiac disease. Cardiol Young 13(1):36–43PubMedCrossRef

Davis JAM, Bass A, Humphrey L et al (2020) Early integration of palliative care in families of children with single ventricle congenital heart defects: a quality improvement project to enhance family support. Pediatr Cardiol 41(1):114–122PubMedCrossRef

Deutsche Herzstiftung e. V. (2018) Herzbericht. https://www.herzstiftung.de/herzbericht

Eicken A, Kolb C, Lange S et al (2006) Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol 107(1):30–35PubMedCrossRef

Galiè N, Humbert M, Vachiery J-L et al (2016) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119PubMedCrossRef

Gewillig M (2005) The fontan circulation. Heart 91(6):839–846PubMedPubMedCentralCrossRef

Gupta S, Giuffre R, Crawford S et al (1998) Covert fears, anxiety and depression in congenital heart disease. Cardiol Young 8(4):491–499PubMedCrossRef

Kozlik-Feldmann R, Ulrich S, zu Knyphausen E et al (2019) Herztransplantation im Kindes-und Jugendalter sowie bei Erwachsenen mit angeborenen Herzfehlern (EMAH); AWMF-sk2 Leitlinie. https://www.awmf.org/uploads/tx_szleitlinien/023-046l_S2k_Herztransplantation-Kinder-Jugendliche_Erwachsene-EMAH-angeborene-Herzfehler_2020-01.pdf. Zugegriffen am 29.02.2020

Kwiatkowska J, Budrejko S, Wasicionek M et al (2020) Long-term follow-up of implantable cardioverter-defibrillators in children: Indications and outcomes. Adv Clin Exp Med 29(1):123–133PubMed

Lindinger A, Schwedler G, Hense H-W (2010) Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr 222(05):321–326PubMedCrossRef

Lipshultz SE, Law YM, Asante-Korang A et al (2019) Cardiomyopathy in children: Classification and diagnosis: a scientific statement from the american heart association. Circulation 140(1):e9–e68PubMedCrossRef

Marino BS (2002) Outcomes after the Fontan procedure. Curr Opin Pediatr 14(5):620–626PubMedCrossRef

Meberg A, Lindberg H, Thaulow E (2005) Congenital heart defects: the patients who die. Acta Paediatr 94(8):1060–1065PubMedCrossRef

Mebus S, Apitz C, Diller G-P et al (2015) Pulmonal arterielle Hypertonie (PAH) im Kindes-und Jugendalter, AWMF- S2k-Leitlinie 023/038. https://www.awmf.org/uploads/tx_szleitlinien/023-038l_S2k_Pulmonal-Arterielle-Hypertoie-PAH-Kinder-Jugendliche_2015-09.pdf. Zugegriffen am 29.02.2020

Rickers C, Läer S, Diller G-P et al (2015) Pädiatrische Kardiologie: Chronische Herzinsuffizienz (S2k-Leitlinie, AWMF-Register Nr. 023/006). https://www.awmf.org/uploads/tx_szleitlinien/023-006l_S2k_Chronische_Herzinsuffizienz_Kinder_Jugendliche_2015-10.pdf. Zugegriffen am 08.03.2020

Sarajuuri A, Jokinen E, Puosi R et al (2007) Neurodevelopmental and neuroradiologic outcomes in patients with univentricular heart aged 5 to 7 years: related risk factor analysis. J Thorac Cardiovasc Surg 133(6):1524–1532PubMedCrossRef

Schranz D (2017) Behandlung der chronischen Herzinsuffizienz im Kindesalter. Monatsschr Kinderheilk 165(11):982–991CrossRef

Schranz D, Bauer A, Reich B et al (2015) Fifteen-year single center experience with the “Giessen Hybrid” approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol 36(2):365–373PubMedCrossRef

Silka MJ, Bar-Cohen Y (2006) Pacemakers and implantable cardioverter-defibrillators in pediatric patients. Heart Rhythm 3(11):1360–1366PubMedCrossRef

Tobler D, Greutmann M, Colman JM et al (2012) End-of-life in adults with congenital heart disease: a call for early communication. Int J Cardiol 155(3):383–387PubMedCrossRef

Troost E, Roggen L, Goossens E et al (2019) Advanced care planning in adult congenital heart disease: transitioning from repair to palliation and end-of-life care. Int J Cardiol 279:57–61PubMedCrossRef

Wik G, Jortveit J, Sitras V et al (2020) Severe congenital heart defects: incidence, causes and time trends of preoperative mortality in Norway. Arch Dis Child 105(8):738–743PubMedCrossRef

www.ukgm.de/ugm_2/deu/ugi_kik/8674.html

Aboussouan LS, Mireles-Cabodevila E (2017) Sleep-disordered breathing in neuromuscular disease: diagnostic and therapeutic challenges. Chest 152(4):880–892PubMedCrossRef

Amaddeo A, Frapin A, Fauroux B (2016) Long-term non-invasive ventilation in children. Lancet Respir Med 4(12):999–1008PubMedCrossRef

Amin R, Sayal P, Syed F et al (2014) Pediatric long-term home mechanical ventilation: twenty years of follow-up from one Canadian center. Pediatr Pulmonol 49(8):816–824PubMedCrossRef

Bach JR, Saporito LR (1996) Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure: a different approach to weaning. Chest 110(6):1566–1571PubMedCrossRef

Bach JR, Campagnolo DI, Hoeman S (1991) Life satisfaction of individuals with Duchenne muscular dystrophy using long-term mechanical ventilatory support. Am J Phys Med Rehabil 70(3):129PubMedCrossRef

Bach JR, Vega J, Mojors J et al (2003) Spinal muscular atrophy type 1. Am J Phys Med Rehabil 82(2):137–142PubMedCrossRef

Bianchi C, Baiardi P (2008) Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil 87(6):461–467PubMedCrossRef

Brito MF, Moreira GA, Pradella-Hallinan M et al (2009) Air stacking and chest compression increase peak cough flow in patients with Duchenne muscular dystrophy. J Bras Pneumol 35(10)

Carnevale FA (2007) Revisiting Goffman’s Stigma: the social experience of families with children requiring mechanical ventilation at home. J Child Health Care 11(1):7–18PubMedCrossRef

Carnevale FA, Leclerc F, Canoui P et al (2006) The moral experience of parents regarding life-support decisions for their critically-ill children: A preliminary study in France. J Child Health Care 10(1):69–82PubMedCrossRef

Chacko A, Sly PD, Gauld L (2020) Polysomnography findings in pediatric spinal muscular atrophy types 1–3. Sleep Med 68:124–130PubMedCrossRef

Dal’Astra APL, Quirino AV, Caixêta JAdS et al (2017) Tracheostomy in childhood: review of the literature on complications and mortality over the last three decades. Braz J Otorhinolaryngol 83(2):207-214

Dellon E, Goggin J, Chen E et al (2018) Defining palliative care in cystic fibrosis: a Delphi study. J Cyst Fibros 17(3):416–421PubMedCrossRef

Dellon EP, Basile M, Hobler MR et al (2020) Palliative care needs of individuals with cystic fibrosis: perspectives of multiple stakeholders. J Palliat Med 23(7):957–963PubMedPubMedCentralCrossRef

Dohna-Schwake C, Ragette R, Teschler H et al (2006) IPPB-assisted coughing in neuromuscular disorders. Pediatr Pulmonol 41(6):551–557PubMedCrossRef

Dohna-Schwake C, Podlewski P, Voit T et al (2008) Non-invasive ventilation reduces respiratory tract infections in children with neuromuscular disorders. Pediatr Pulmonol 43(1):67–71PubMedCrossRef

Eagle M, Baudouin SV, Chandler C et al (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 12(10):926–929PubMedCrossRef

Earle EA, Clarke SA, Elsar C et al (2006) „Building a new normality“: mothersïexperiences of caring for a child with acute lymphoblastic leukaemia. Child Care Health Dev 33(2):155–160CrossRef

Fauroux B, Sardet A, Foret D (1995) Home treatment for chronic respiratory failure in children: a prospective study. Eur Respir J 8(12):2062–2066PubMedCrossRef

Finder JD, Birnkrant D, Carll J et al (2004) Respiratory care of the patient with duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 170(4):456–465PubMedCrossRef

Finkel RS, Mercuri E, Meyer OH et al (2018) Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord 28(3):197–207PubMedCrossRef

Finkel RS, Mercuri E, Darras BT et al. (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377:1723-32

Goldberg A (1999) Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation – a consensus conference report. Chest, 116, S 521–534

González R, Bustinza A, Fernandez SN et al (2017) Quality of life in home-ventilated children and their families. Eur J Pediatr 176(10):1307–1317PubMedCrossRef

Gozal D (1998) Congenital central hypoventilation syndrome: an update. Pediatr Pulmonol 26(4):273–282PubMedCrossRef

Grychtol R, Chan EY (2018) Use of non-invasive ventilation in cerebral palsy. Arch Dis Child 103(12):1170–1177PubMedCrossRef

Guo W, Cao L, Chang L (2019) Clinical characteristics of non-invasive ventilation treatment in children with spinal muscular atrophy and sleep disordered breathing. Zhonghua Er Ke Za Zhi 57(10):792–796PubMed

Hein H, Rasche K, Wiebel M et al (2006) Empfehlung zur Heim-und Langzeitbeatmung. Med Klin 101(2):148–152CrossRef

Hirschfeld S, Exner G, Luukkaala T et al (2008) Mechanical ventilation or phrenic nerve stimulation for treatment of spinal cord injury-induced respiratory insufficiency. Spinal Cord 46(11):738–742PubMedCrossRef

Hodson M, Madden B, Steven M et al (1991) Non-invasive mechanical ventilation for cystic fibrosis patients--a potential bridge to transplantation. Eur Respir J 4(5):524–527PubMedCrossRef

Hov B, Andersen T, Hovland V et al (2018) The clinical use of mechanical insufflation-exsufflation in children with neuromuscular disorders in Europe. Paediatr Respir Rev 27:69–73PubMed

Hull J, Aniapravan R, Chan E et al (2012) British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax 67(Suppl 1):i1–i40PubMedCrossRef

IQWiG (2020) Spinale Muskelatrophie (SMA): Neugeborenenscreening verspricht einen Nutzen. https://www.iqwig.de/de/presse/pressemitteilungen/2020/spinale-muskelatrophie-sma-neugeborenenscreening-verspricht-einen-nutzen.12933.html. Zugegriffen am 05.05.2020

Ishikawa Y, Bach JR, Komaroff E et al (2008) Cough augmentation in Duchenne muscular dystrophy. Am J Phys Med Rehabil 87(9):726–730PubMedCrossRef

Kang S-W, Bach JR (2000) Maximum insufflation capacity: vital capacity and cough flows in neuromuscular disease. Am J Phys Med Rehabil 79(3):222–227PubMedCrossRef

Kapnadak SG, Dimango E, Hadjiliadis D et al (2020) Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. J Cyst Fibros 19(3):344–354PubMedCrossRef

Kohler M, Clarenbach CF, Böni L et al (2005) Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med 172(8):1032–1036PubMedCrossRef

Konagaya M, Sakai M, Wakayama T et al (2005) Effect of intermittent positive pressure ventilation on life-span and causes of death in Duchenne muscular dystrophy. Rinsho Shinkeigaku 45(9):643–646PubMed

Landfeldt E, Thompson R, Sejersen T et al (2020) Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur J Epidemiol 35(7):643–653PubMedPubMedCentralCrossRef

Leger P, Paulus J (2006) [Recommendations of HAS: practical issues in home non-invasive ventilation in patients with neuromuscular disease]. Revue de maladies repiratoires 23(4 Suppl):13s141-3

Li KK, Riley RW, Guilleminault C (2000) An unreported risk in the use of home nasal continuous positive airway pressure and home nasal ventilation in children. Chest 117(3):916–918PubMedCrossRef

Lloyd-Owen S, Donaldson G, Ambrosino N et al (2005) Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 25(6):1025–1031PubMedCrossRef

Luo J, Duke T, Chisti MJ et al (2019) Efficacy of high-flow nasal cannula vs standard oxygen therapy or nasal continuous positive airway pressure in children with respiratory distress: a meta-analysis. J Pediatr 215:199–208.e8

Manni R, Ottolini A, Cerveri I et al (1989) Breathing patterns and HbSaO 2 changes during nocturnal sleep in patients with Duchenne muscular dystrophy. J Neurol 236(7):391–394PubMedCrossRef

Martiniano SL, Sagel SD, Zemanick ET (2016) Cystic fibrosis: a model system for precision medicine. Curr Opin Pediatr 28(3):312–317PubMedPubMedCentralCrossRef

Mehta S, Hill NS (2001) Noninvasive ventilation. Am J Respir Crit Care Med 163(2):540–577PubMedCrossRef

Mellies U, Dohna-Schwake C (2005) Intermittierende Selbstbeatmung in der Pädiatrie. In: Schönhofer B (Hrsg) Nichinvasive Beatmung. Ecomed, Heidelberg

Mellies U, Goebel C (2014) Optimum insufflation capacity and peak cough flow in neuromuscular disorders. Ann Am Thorac Soc 11(10):1560–1568PubMedCrossRef

Mellies U, Ragette R, Schwake C et al (2003a) Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders. Neuromuscul Disord 13:123–128PubMedCrossRef

Mellies U, Ragette R, Schwake CD et al (2003b) Longterm noninvasive ventilation in children and adolescents with neuromuscular disorders. Eur Respir J 22(4):631–636PubMedCrossRef

Mellies U, Dohna-Schwake C, Stehling F et al (2004) Sleep disordered breathing in spinal muscular atrophy. Neuromuscul Disord 14(12):797–803PubMedCrossRef

Mellies U, Dohna-Schwake C, Voit T (2005) Respiratory function assessment and intervention in neuromuscular disorders. Curr Opin Neurol 18(5):543–547PubMedCrossRef

Mercuri E, Darras BT, Chiriboga CA et al (2018) Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med 378(7):625–635PubMedCrossRef

Moran F, Bradley JM, Piper AJ (2017) Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev(2):CD002769.pub5

Narayanaswami P, Bertorini TE, Pourmand R et al (2000) Long-term tracheostomy ventilation in neuromuscular diseases: patient acceptance and quality of life. Neurorehabil Neural Repair 14(2):135–139PubMedCrossRef

Nygren-Bonnier M, Markström A, Lindholm P et al (2009) Glossopharyngeal pistoning for lung insufflation in children with spinal muscular atrophy type II. Acta Paediatr 98(8):1324–1328PubMedCrossRef

Paditz E, Zieger S, Bickhardt J et al (2000) Lebensqualität unter Heimbeatmung im Kindes-, Jugend-und jungen Erwachsenenalter: unterschiedliche Sichtweisen von Eltern und Kindern. Somnologie 4(1):13–19CrossRef

Pavone M, Verrillo E, Onofri A et al (2020) Characteristics and outcomes in children on long-term mechanical ventilation: the experience of a pediatric tertiary center in Rome. Ital J Pediatr 46(1):12PubMedPubMedCentralCrossRef

Phillips MF, Smith PE, Carroll N et al (1999) Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med 160(1):198–202PubMedCrossRef

Pinto T, Chatwin M, Banfi P et al (2017) Mouthpiece ventilation and complementary techniques in patients with neuromuscular disease: a brief clinical review and update. Chron Respir Dis 14(2):187-93

Ragette R, Mellies U, Schwake C et al (2002) Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 57(8):724–728PubMedPubMedCentralCrossRef

Rideau Y, Jankowski L, Grellet J (1981) Respiratory function in the muscular dystrophies. Muscle Nerve 4(2):155–164PubMedCrossRef

Romero F, Gambarrutta C, Garcia-Forcada A et al (2012) Long-term evaluation of phrenic nerve pacing for respiratory failure due to high cervical spinal cord injury. Spinal Cord 50(12):895–898PubMedCrossRef

Simonds A (2006) Risk management of the home ventilator dependent patient. Thorax 61:369–371PubMedPubMedCentralCrossRef

Simonds A, Muntoni F, Heather S et al (1998) Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 53(11):949–952PubMedPubMedCentralCrossRef

Simonds AK (2004) Living and dying with respiratory failure: facilitating decision making. Chron Respir Dis 1(1):56–59PubMedCrossRef

Simonds AK (2005) Ethical aspects of home long term ventilation in children with neuromuscular disease. Paediatr Respir Rev 6:209–214PubMedCrossRef

Simonds AK, Ward S, Heather S et al (2000) Outcome of paediatric domicilliary mask ventilation in neuromuscular and skeletal disease. Eur Respir J 16(3):476–481PubMedCrossRef

Sivasothy P, Brown L, Smith I et al (2001) Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax 56(6):438–444PubMedPubMedCentralCrossRef

Smith PE, Calverley PM, Edwards RH (1988) Hypoxemia during sleep in Duchenne muscular dystrophy. Am J Respir Crit Care Med 137(4):884–888

Tzeng A, Bach JR (2000) Preventing pulmonary morbidity for patients with neuromuscular disease. Chest 118:1390–1396PubMedCrossRef

Vianello A, Bevilacqua M, Salvador V et al (1994) Long-term nasal intermittent positive pressure ventilation in advanced Duchenne’s muscular dystrophy. Chest 105(2):445–448PubMedCrossRef

Vianello A, Corrado A, Arcaro G et al (2005) Mechanical insufflation–exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections. Am J Phys Med Rehabil 84(2):83–88PubMedCrossRef

Villa MP, Pagani J, Ambrosio R et al (2002) Mid-face hypoplasia after long-term nasal ventilation. Am J Respir Crit Care Med 166(8):1142–1143PubMedCrossRef

Wadman RI, van der Pol WL, Bosboom WMJ et al (2019) Drug treatment for spinal muscular atrophy type I. Cochrane Database Syst Rev(12):CD006281.pub5

Wallgren-Pettersson C, Bushby K, Mellies U et al (2004) 117th ENMC workshop: ventilatory support in congenital neuromuscular disorders – congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4–6 April 2003, Naarden, The Netherlands. Neuromuscul Disord 14(1):56–69PubMedCrossRef

Weese-Mayer DE, Berry-Kravis EM, Ceccherini I et al (2010) An official ATS clinical policy statement: congenital central hypoventilation syndrome: genetic basis, diagnosis, and management. Am J Respir Crit Care Med 181(6):626–644PubMedCrossRef

Windisch W, Walterspacher S, Siemon K et al (2010) Guidelines for non-invasive and invasive mechanical ventilation for treatment of chronic respiratory failure. Pneumologie 64(10):640–652PubMedCrossRef

Windisch W, Dreher M, Geiseler J et al (2017) S2k-leitlinie: Nichtinvasive und invasive Beatmung als Therapie der chronischen respiratorischen Insuffizienz–Revision 2017. Pneumologie 71(11):722–795PubMedCrossRef

Zerres K, Wirth B, Rudnik-Schöneborn S (1997) Spinal muscular atrophy – clinical and genetic correlations. Neuromuscul Disord 7(3):202–207PubMedCrossRef

Anderson BT, Feinstein JA, Kramer RE et al (2018) The approach and safety of esophageal dilation for treatment of strictures in children with epidermolysis bullosa. J Pediatr Gastroenterol Nutr 67(6):701–05

Beissenhirtz A, Hübner-Möhler B (2018) Epidermolysis bullosa (EB) - Tipps zum Umgang mit Schmerzen beim Verbandswechsel. Schmerz Schmerzmanagement 2(2):19

Bodán RC (2016) Epidermolysis bullosa: an insider’s perspective to a rare genetic connective tissue disorder. J Dermatol Nurses Assoc 8(1):46-56

Bruckner-Tuderman L (2019) Newer treatment modalities in Epidermolysis bullosa. Indian Dermatol Online J 10(3):244-50

Brun J, Chiaverini C, Devos C et al (2017) Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex. Orphanet J Rare Dis 12(1):119

Chiu YK, Prendiville JS, Bennett SM et al (1999) Pain management of junctional Epidermolysis bullosa in an 11-year-old boy. Pediatr Dermatol 16(6):465–468

DEBRA Austria (2020a) Therapie und Behandlung. https://www.eb-haus.org/eb-handbuch/therapie-behandlung/

DEBRA Austria (2020b) Therapie und Behandlung. Wundversorgung. https://www.eb-haus.org/eb-handbuch/therapie-behandlung/wundversorgung/

Denyer J, Pillay E, Clapham J (2017) Best practice guidelines for skin and wound care in Epidermolysis bullosa. An international consensus. Wounds International, London. http://www.debra-international.org/fileadmin/media_data/4_DEBRA_International/CPGs/Guidelines/International_Consensus_Best_Practice_Guidelines_Skin_and_Wound_Care_in_Epidermolysis_Bullosa.pdf

Diem A (2009) Das tägliche Leben mit EB. https://www.eb-haus.org/eb-handbuch/alltag-mit-eb/leben-mit-eb/

Diem A (2012) Notfallinfo Unfall eines EB-Betroffenen. https://www.eb-haus.org/ambulanz/im-notfall/unfall-eines-eb-betroffenen/

Feinstein JA, Jambal P, Peoples K et al (2019) Assessment of the timing of milestone clinical events in patients with epidermolysis bullosa from North America. JAMA dermatology 155(2):196–203

Fine JD, Bruckner-Tuderman L, Eady RA et al (2014) Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 70(6):1103–1126

Fine JD, Johnson LB, Weiner M et al (2004) Assessment of mobility, activities and pain different subtypes of epidermolysis bullosa. Clin Exp Dermatol 29(2):122–127

Fine J-D, Eady R, Bauer E et al (2008) The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB

Goldschneider KR, Good J, Harrop E et al (2014) Pain care for patients with epidermolysis bullosa: best care practice guidelines. BMC Med 12(1):178

Gottschalk A, Venherm S, Vowinkel T et al (2010) Anesthesia for balloon dilatation of esophageal strictures in children with epidermolysis bullosa dystrophica: from intubation to sedation. Curr Opin Anaesthesiol 23(4):518-522

Hartenstein-Pinter A, Hübner-Möhler B, Zernikow B et al (2020) Verbandsmaterial bei Kindern mit Epidermolysis bullosa. Eine qualitative Studie zu den Erfahrungen von Eltern und betroffenen. Kindern Schmerz 34:156-165

Has C, Bauer JW, Bodemer C et al (2020) Consensus re-classification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol epub ahead of print

Haynes LSRD, Atherton D, Clayden G (1997) Constipation in epidermolysis bullosa: successful treatment with a liquid fiber-containing formula. Pediatr Dermatol 14(5):393

Herod J, Denyer J, Goldman A et al (2002) Epidermolysis bullosa in children: pathophysiologie, anaesthesia and pain management. Paediatr Anaesth 12:388-397

Jacków J, Guo Z, Hansen C et al (2019) CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells. Proc Natl Acad Sci U S A 116(52):26846–26852

Krämer SM, Serrano MC, Zillmann G et al (2012) Oral health care for patients with epidermolysis bullosa - best clinical practice guidelines. Int J Paediatr Dent 22(s1):1-35

Küchler S, Wolf NB, Heilmann S et al (2010) 3D-wound healing model: influence of morphine and solid lipid nanoparticles. J Biotechnol 148(1):24-30

Lin Y-C, Golianu B (2006) Anesthesia and pain management for pediatric patients with dystrophic epidermolysis bullosa. J Clin Anesth 18(4):268–271

Margari F, Lecce PA, Santamato W et al (2010) Psychiatric symptoms and quality of life in patients affected by Epidermolysis bullosa. J Clin Psychol Med Settings 17(4):333–339

Martin K, Geuens S, Asche JK et al (2019) Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines. Orphanet J Rare Dis 14(1):133

Orphanet (2019) Orhphanet Series Report - Prevalence of rare diseases: Bibliographic data – January 2019 – Number 1. https://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf

Petersen BW, Arbuckle HA, Berman S (2015) Effectiveness of saltwater baths in the treatment of epidermolysis bullosa. Pediatr Dermatol 32(1):60–63

Rashidghamat E, Kadiyirire T, Ayis S et al (2019) A phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol [Epub ahead of print]

Reimer A, Bruckner-Tuderman L, Ott H (2018) Mapping health care of rare diseases: the example of Epidermolysis bullosa in Germany. Orphanet J Rare Dis 13(1):197

van Scheppingen C, Lettinga AT, Duipmans JC et al (2008a) The main problems of parents of a child with epidermolysis bullosa. Qual Health Res 18(4):545–556

van Scheppingen C, Lettinga AT, Duipmans JC et al (2008b) Main problems experienced by children with Epidermolysis bullosa: a qualitative study with semi-structured interviews. Acta Derm Venereol 88(2):143–150

Stein C, Küchler S (2013) Targeting inflammation and wound healing by opioids. Trends Pharmacol Sci 34(6):303–312

Van den Heuvel I, Boschin M, Langer M et al (2013) Anesthetic management in pediatric patients with epidermolysis bullosa: a single center experience. Minerva Anestesiol 79(7):727–732

Williams EF, Gannon K, Soon K (2011) The experiences of young people with epidermolysis bullosa simplex: a qualitative study. J Health Psychol 16(5):701–710

Zernikow B (Hrsg) (2021) Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle. Springer, Berlin/Heidelberg

Abad C, Fearday A, Safdar N (2010) Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect 76(2):97–102PubMedPubMedCentralCrossRef

Allegranzi B, Pittet D (2009) Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect 73(4):305–315PubMedCrossRef

Arbeitsgruppe der Deutschen Gesellschaft für Pädiatrische Infektiologie, Paed IC Projekt (2014) Infektionspräventives Vorgehen bei Nachweis von MRGN im Kindesalter. Hyg Med 39(10):392–399

Bundesministerium der Justiz und für Verbraucherschutz, Bundesamt für Justiz (2000) Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz – IfSG). Bundesgesetzblatt 1:1045. https://www.gesetze-im-internet.de/ifsg/. Zugegriffen am 21.03.2020

Chen Y-C, Lin C-F, Rehn Y-JF et al (2017) Reduced nosocomial infection rate in a neonatal intensive care unit during a 4-year surveillance period. J Chin Med Assoc 80(7):427–431PubMedCrossRef

Dancer SJ (2009) The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect 73(4):378–385PubMedCrossRef

Dancer SJ (2010) Control of transmission of infection in hospitals requires more than clean hands. Infect Control Hosp Epidemiol 31(9):958–960PubMedCrossRef

Day HR, Perencevich EN, Harris AD et al (2011) Do contact precautions cause depression? A two-year study at a tertiary care medical centre. J Hosp Infect 79(2):103–104PubMedPubMedCentralCrossRef

Deutscher Bundestag (2011) Amtliche Begründung zur Änderung des Infektionsschutzgesetzes. Drucksache 17/5178 http://dip21.bundestag.de/dip21/btd/17/051/1705178.pdf. Zugegriffen am 26.03.2020

Donskey CJ (2004) The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 39(2):219PubMedCrossRef

Erasmus V, Daha TJ, Brug H et al (2010) Systematic review of studies on compliance with hand hygiene guidelines in hospital care. Infect Control Hosp Epidemiol 31(3):283–294PubMedCrossRef

Gemeinsamer Bundesausschuss zur Verordnung von Spezialisierter Ambulanter Palliativversorgung (2010) Richtlinie des Gemeinsamen Bundesausschusses zur Verordnung von spezialisierter ambulanter Palliativversorgung (Spezialisierte Ambulante Palliativversorgungs-Richtlinie / SAPV-RL). Berlin. https://www.g-ba.de/downloads/62-492-437/SAPV-RL_2010-04-15.pdf

Giannini MA, Nance D, McCullers JA (2009) Are toilet seats a vector for transmission of methicillin-resistant Staphylococcus aureus? Am J Infect Control 37(6):505–506PubMedPubMedCentralCrossRef

Kommission für Krankenhaushygiene und Infektionsprävention beim Robert-Koch-Institut (2008) Kommentar zu den Empfehlungen zur Prävention und Kontrolle von MRSA-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen. Hinweise zu Risikopopulationen für die Kolonisation mit MRSA. Epidemiologisches Bulletin des Robert-Koch-Instituts, Berlin, S 363–364.

Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2020) Surveillance von nosokomialen Infektionen. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 2:228

Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (RKI) (2016) Händehygiene in Einrichtungen des Gesundheitswesens. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 9:1189

Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut B (2002) Ausbruchsmanagement und strukturiertes Vorgehen bei gehäuftem Auftreten nosokomialer Infektionen Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsblatt 45:180–186CrossRef

Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut B (2009) Personelle und organisatorische Voraussetzungen zur Prävention nosokomialer Infektionen - Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention. Bundesgesundheitsbl 53:951–962

Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut B (2011) Definition der Multiresistenz gegenüber Antibiotika bei gramnegativen Stäbchen im Hinblick auf Maßnahmen zur Vermeidung der Weiterverbreitung, Bd 36. Epidemiologisches Bulletin des Robert-Koch-Instituts Berlin:337–339

Kramer A, Christiansen B, Exner M et al (2000) Händehygiene. Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert-Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 43:230–233

Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6(1):130PubMedPubMedCentralCrossRef

Lambe KA, Lydon S, Madden C et al (2019) Hand hygiene compliance in the ICU: a systematic review. Crit Care Med

Lund-Nielsen B, Adamsen L, Gottrup F et al (2011) Qualitative bacteriology in malignant wounds – a prospective, randomized, clinical study to compare the effect of honey and silver dressings. Ostomy Wound Manage 57(7):28PubMed

Mohr Edokpolo C (2011) Multiresistente Erreger in Langzeitpflegeeinrichtungen. Hyg Med 36(3):81

Pittet D, Panesar S, Wilson K et al (2011) Involving the patient to ask about hospital hand hygiene: a National Patient Safety Agency feasibility study. J Hosp Infect 77(4):299–303PubMedCrossRef

Raymond J, Aujard Y (2000) Nosocomial infections in pediatric patients a European, multicenter prospective study. Infect Control Hosp Epidemiol 21(04):260–263PubMedCrossRef

Reichardt C, Eberlein-Gonska M, Schrappe M et al (2009) Clean hands campaign. No chance for hospital infections! Unfallchirurg 112(7):679–682PubMedCrossRef

Reichardt C, Königer D, Bunte-Schönberger K et al (2013) Three years of national hand hygiene campaign in Germany: what are the key conclusions for clinical practice? J Hosp Infect 83:S11–SS6PubMedCrossRef

Robert Koch Institut (RKI) (2016) Händehygiene in Einrichtungen des Gesundheitswesens Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (RKI). Bundesgesundheitsblatt 59:1189–1220CrossRef

Robert Koch Institut (RKI) (2019) EUCAST-Neudefinition der Kategorie „I“ – zum Umgang hinsichtlich der Meldepflicht. Epidemiol Bull 9:84

Sax H, Allegranzi B, Uckay I et al (2007) ‘My five moments for hand hygiene’: a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect 67(1):9–21PubMedCrossRef

Schmidt P, Hasan C, Simon A et al (2020) Multidrug-resistant bacteria in a paediatric palliative care inpatient unit: results of a one year surveillance. GMS Hyg Infect Control 15, doc3

Simon A, Müller A, Franz A et al (2009) Erfassung nosokomialer und Gesundheitssystem-assoziierter Infektionen in der Pädiatrie–Gemeinsame Stellungnahme zur Erfassung nosokomialer und gesundheitssystemassoziierter Infektionen in der Pädiatrie. Monatsschr Kinderheilk 157:166–172CrossRef

Simon A, Exner M, Engelhart S et al (2011) Umgang mit haMRSA kolonisierten Kindern und Jugendlichen im ambulanten Betreuungsumfeld. Hyg Med 36:30–35

Statistisches Bundesamt (Destatis) (2020) Statistisches Bundesamt Deutschland - GENESIS-Online. https://www-genesis.destatis.de/genesis//online?operation=table&code=23211-0003. Zugegriffen 20.05.2020

Urrea M, Pons M, Serra M et al (2003) Prospective incidence study of nosocomial infections in a pediatric intensive care unit. Pediatr Infect Dis J 22(6):490–493PubMedCrossRef

Wissenschaftlicher Beirat der „Aktion saubere Hände“ (2011) Positionspapier zur Einreibemethode der Händedesinfektion. 30.09.2011

Abad C, Fearday A, Safdar N (2010) Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect 76(2):97–102

Allegranzi B, Pittet D (2009) Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect 73(4):305–315

Arbeitsgruppe der Deutschen Gesellschaft für Pädiatrische Infektiologie, Paed IC Projekt (2014) Infektionspräventives Vorgehen bei Nachweis von MRGN im Kindesalter. Hyg Med 39(10):392–399

Bundesministerium der Justiz und für Verbraucherschutz, Bundesamt für Justiz (2000) Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz – IfSG). Bundesgesetzblatt 1, 1045. https://www.gesetze-im-internet.de/ifsg/. Zugegriffen am 21.03.2020

Chen Y-C, Lin C-F, Rehn Y-JF et al (2017) Reduced nosocomial infection rate in a neonatal intensive care unit during a 4-year surveillance period. J Chin Med Assoc 80(7):427–431

Dancer SJ (2010) Control of transmission of infection in hospitals requires more than clean hands. Infect Control Hosp Epidemiol 31(9):958–960

Dancer SJ (2009) The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect 73(4):378–385

Day HR, Perencevich EN, Harris AD et al (2011) Do contact precautions cause depression? A two-year study at a tertiary care medical centre. J Hosp Infect 79(2):103–104

Deutscher Bundestag (2011) Amtliche Begründung zur Änderung des Infektionsschutzgesetzes. Drucksache 17/5178 http://dip21.bundestag.de/dip21/btd/17/051/1705178.pdf. Zugegriffen am 26.03.2020

Donskey CJ (2004) The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 39(2):219

Erasmus V, Daha TJ, Brug H et al (2010) Systematic review of studies on compliance with hand hygiene guidelines in hospital care. Infect Control Hosp Epidemiol 31(3):283–294

Gemeinsamer Bundesausschuss zur Verordnung von Spezialisierter Ambulanter Palliativversorgung (2010) Richtlinie des Gemeinsamen Bundesausschusses zur Verordnung von spezialisierter ambulanter Palliativversorgung (Spezialisierte Ambulante Palliativversorgungs-Richtlinie / SAPV-RL). Berlin, https://www.g-ba.de/downloads/62-492-437/SAPV-RL_2010-04-15.pdf

Giannini MA, Nance D, McCullers JA (2009) Are toilet seats a vector for transmission of methicillin-resistant Staphylococcus aureus? Am J Infect Control 37(6):505-6

Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) (2020) Surveillance von nosokomialen Infektionen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2:228

Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut B (2002) Ausbruchsmanagement und strukturiertes Vorgehen bei gehäuftem Auftreten nosokomialer Infektionen. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsblatt 45:180-6

Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6(1):130

Lambe KA, Lydon S, Madden C et al (2019) Hand hygiene compliance in the ICU: a systematic review. Crit Care Med 47(9):1251–1257

Mohr Edokpolo C (2011) Multiresistente Erreger in Langzeitpflegeeinrichtungen. Hyg Med 36(3):81

Pittet D, Panesar S, Wilson K et al (2011) Involving the patient to ask about hospital hand hygiene: a National Patient Safety Agency feasibility study. J Hosp Infect 77(4):299–303

Raymond J, Aujard Y (2000) Nosocomial infections in pediatric patients a European, multicenter prospective study. Infect Control Hosp Epidemiol 21(04):260–263

Reichardt C, Eberlein-Gonska M, Schrappe M et al (2009) Clean hands campaign. No chance for hospital infections! Unfallchirurg 112(7):679–682

Reichardt C, Königer D, Bunte-Schönberger K et al (2013) Three years of national hand hygiene campaign in Germany: what are the key conclusions for clinical practice? J Hosp Infect 83:S11–S6

Robert Koch Institut (RKI) (2019) EUCAST-Neudefinition der Kategorie „I“ – zum Umgang hinsichtlich der Meldepflicht. Epidemiol Bull 9:84

Sax H, Allegranzi B, Uckay I et al (2007) ‘My five moments for hand hygiene’: a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect 67(1):9–21

Schmidt P, Hasan C, Simon A et al (2020) Multidrug-resistant bacteria in a paediatric palliative care inpatient unit: results of a one year surveillance. GMS Hyg Infect Control 15

Simon A, Exner M, Engelhart S et al (2011) Umgang mit haMRSA kolonisierten Kindern und Jugendlichen im ambulanten Betreuungsumfeld. Hyg Med 36:30–35

Simon A, Müller A, Franz A et al. (2009) Erfassung nosokomialer und Gesundheitssystem-assoziierter Infektionen in der Pädiatrie–Gemeinsame Stellungnahme zur Erfassung nosokomialer und gesundheitssystemassoziierter Infektionen in der Pädiatrie. Monatsschr Kinderheilk 157:166–172

Urrea M, Pons M, Serra M et al. (2003) Prospective incidence study of nosocomial infections in a pediatric intensive care unit. Pediatr Infect Dis J 22(6):490-3

Wissenschaftlicher Beirat der „Aktion saubere Hände“ (2011) Positionspapier zur Einreibemethode der Händedesinfektion. 30.09.2011

Adams D, Karpanen T, Worthington T et al (2006) Infection risk associated with a closed luer access device. J Hosp Infect 62(3):353–357PubMedCrossRef

Anderson DM, Pesaturo KA, Casavant J et al (2013) Alteplase for the treatment of catheter occlusion in pediatric patients. Ann Pharmacother 47(3):405–409PubMedCrossRef

Arbeitsgruppe KRINKO-BfArM-RKI (2016) Bericht der Arbeitsgruppe KRINKO-BfArM-RKI: Zu spezifischen Fragen bezüglich Rekonstitution, Zubereitung und Applikation von Arzneimitteln und Infusionslösungen sowie zur Hautantiseptik. Epidemiol Bulletin des Robert Koch-Instituts, Berlin 20:173–178

Austin PD, Elia M (2009) A systematic review and meta-analysis of the risk of microbial contamination of aseptically prepared doses in different environments. J Pharm Pharm Sci 12(2):233–242PubMedCrossRef

Bertoglio S, Rezzo R, Merlo FD et al (2013) Pre-filled normal saline syringes to reduce totally implantable venous access device-associated bloodstream infection: a single institution pilot study. J Hosp Infect 84(1):85–88PubMedCrossRef

Bisseling TM, Willems MC, Versleijen MW et al (2010) Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr 29(4):464–468PubMedCrossRef

Blaney M, Shen V, Kerner JA et al (2006) Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study). J Vasc Interv Radiol 17(11 Pt 1):1745–1751PubMedCrossRef

Bradshaw JH, Puntis JW (2008) Taurolidine and catheter-related bloodstream infection: a systematic review of the literature. J Pediatr Gastroenterol Nutr 47(2):179–186PubMedCrossRef

Chesshyre E, Goff Z, Bowen A et al (2015) The prevention, diagnosis and management of central venous line infections in children. J Infect 71(Suppl 1):S59–S75PubMedCrossRef

Chu HP, Brind J, Tomar R et al (2012) Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock. J Pediatr Gastroenterol Nutr 55(4):403–407PubMedCrossRef

Cullis PS, McKee RF (2011) Taurolidine lock - experience from the West of Scotland. Clin Nutr 30(3):399–400PubMedCrossRef

Ellger B, Kiski D, Diem E et al (2011) Non-return valves do not prevent backflow and bacterial contamination of intravenous infusions. J Hosp Infect 78(1):31–35PubMedCrossRef

Engelhart S, Exner M, Simon A (2015) In vitro study on the disinfectability of two split-septum needle-free connection devices using different disinfection procedures. GMS Hyg Infect Control 10:Doc17PubMedPubMedCentral

Holroyd JL, Paulus DA, Rand KH et al (2014) Universal intravenous access cleaning device fails to sterilize stopcocks. Anesth Analg 118(2):333–343PubMedCrossRef

Hubner NO, Siebert J, Kramer A (2010) Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacol Physiol 23(5):244–258PubMedCrossRef

Jack T, Brent BE, Boehne M et al (2010) Analysis of particulate contaminations of infusion solutions in a pediatric intensive care unit. Intensive Care Med 36(4):707–711PubMedPubMedCentralCrossRef

Jack T, Boehne M, Brent BE et al (2012) In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial. Intensive Care Med 38(6):1008–1016PubMedPubMedCentralCrossRef

Jurewitsch B, Jeejeebhoy KN (2005) Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections. Clin Nutr 24(3):462–465PubMedCrossRef

Jurewitsch B, Lee T, Park J et al (1998) Taurolidine 2 % as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr 22(4):242–244

Liu H, Liu H, Deng J et al (2014) Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. Blood Purif 37(3):179–187PubMedCrossRef

Lopez-Briz E, Ruiz-Garcia V (2005) Effectiveness of heparin versus NaCl 0,9 % in central venous catheter flushing. A systematic review. Farm Hosp 29(4):258–264

Maragakis LL, Bradley KL, Song X et al (2006) Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 27(1):67–70PubMedCrossRef

Marschall J, Mermel LA, Fakih M et al (2014) Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35(7):753–771PubMedCrossRef

Pohl F, Hartmann W, Holzmann T et al (2014) Risk of infection due to medical interventions via central venous catheters or implantable venous access port systems at the middle port of a three-way cock: luer lock cap vs. luer access split septum system (Q-Syte). BMC Infect Dis 14:41PubMedPubMedCentralCrossRef

Schlicht A, Fleischhack G, Herdeis C et al (2009) In vitro investigation of the exposure time necessary to yield a 5 log reduction of clinicall relevant bacteria by a taurolidine containing antimicrobial catheter lock solution. Hyg Med 34(9):343–345

Shah CB, Mittelman MW, Costerton JW et al (2002) Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 46(6):1674–1679PubMedPubMedCentralCrossRef

Shen V, Li X, Murdock M et al (2003) Recombinant tissue plasminogen activator (alteplase) for restoration of function to occluded central venous catheters in pediatric patients. J Pediatr Hematol Oncol 25(1):38–45PubMedCrossRef

Simon A, Furtwängler R, Laws HJ et al (2017) Evidenz-basierte Empfehlungen zur Anwendung dauerhaft implantierter, zentralvenöser Zugänge in der pädiatrischen Onkologie. mhp-Verlag GmbH, Wiesbaden

Smith JS, Kirksey KM, Becker H et al (2011) Autonomy and self-efficacy as influencing factors in nurses’ behavioral intention to disinfect needleless intravenous systems. J Infus Nurs 34(3):193–200PubMedCrossRef

Stucki C, Sautter AM, Favet J et al (2009) Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality. Am J Health Syst Pharm 66(22):2032–2036PubMedCrossRef

Tan M, Lau J, Guglielmo BJ (2014) Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. Ann Pharmacother 48(5):607–615PubMedCrossRef

Tietz A, Frei R, Dangel M et al (2005) Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients. Infect Control Hosp Epidemiol 26(8):703–707PubMedCrossRef

Toure A, Lauverjat M, Peraldi C et al (2012) Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients. Clin Nutr 31(4):567–570PubMedCrossRef

Traub WH, Leonhard B, Bauer D (1993) Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy 39(5):322–330PubMedCrossRef

Trautmann M, Kreutzberger M, Bobic R et al (2012) Disinfection of a needleless connector with alcohol-based disinfectant wipes – an experimental study. Hyg Med 37(9):354–359

Vonberg RP, Gastmeier P (2007) Hospital-acquired infections related to contaminated substances. J Hosp Infect 65(1):15–23PubMedCrossRef

Wanten GJA, Bisseling TM (2011) Responding letter to editor - Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr 30(3):401

Wolf J, Shenep JL, Clifford V et al (2013) Ethanol lock therapy in pediatric hematology and oncology. Pediatr Blood Cancer 60(1):18–25PubMedCrossRef

Zacharioudakis IM, Zervou FN, Arvanitis M et al (2014) Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Clin Infect Dis 59(12):1741–1749PubMedCrossRef

Association for Children with Life-threatening or Terminal Conditions and their Families (ACT), National Council for Hospice and Specialist Palliative Care Services (NCHSPCS), Scottish Partnership Agency for Palliative and Cancer Care (SPAPCC) (2001) Palliative care for young people aged 13-24. ACT, NCHSPCS, SPAPCC Bristol, London, Edinburgh UK

Wikipedia (2020) Adoleszenz. https://de.wikipedia.org/wiki/Adoleszenz. Zugegriffen am 24.02.2020

Bredel-Geißler A, Peters H, Gaese F et al (2017) Qualitätszirkel Transition in Sozialpädiatrischen Zentren. Deutsche Gesellschaft für Sozialpädiatrie und Jugendmedizin e.V. (DGSPJ), Berlin, https://www.dgspj.de/wp-content/uploads/qualitaetssicherung-papiere-transition-2017.pdf

Cooley W, Sagerman P, Pediatrics AAo et al (2011) Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics 128(1):182

Dobbels F, Ruppar T, De Geest S et al (2010) Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr Transplant 14(5):603–613PubMedCrossRef

Doug M, Adi Y, Williams J et al (2009) Transition to adult services for children and young people with palliative care needs: a systematic review. Arch Dis Child 96(1):78–84PubMedCrossRef

Fraser LK, Childs AM, Miller M et al (2012a) A cohort study of children and young people with progressive neuromuscular disorders: clinical and demographic profiles and changing patterns of referral for palliative care. Palliat Med 26(7):924–929PubMedCrossRef

Fraser LK, Miller M, Hain R et al (2012b) Rising national prevalence of life-limiting conditions in children in england. Pediatrics 129(4):e923–e9e9PubMedCrossRef

Fraser LK, Lidstone V, Miller M et al (2014) Patterns of diagnoses among children and young adults with life-limiting conditions: A secondary analysis of a national dataset. Palliat Med 28(6):513–520PubMedCrossRef

Kirk S, Fraser C (2014) Hospice support and the transition to adult services and adulthood for young people with life-limiting conditions and their families: A qualitative study. Palliat Med 28(4):342–352PubMedCrossRef

Linebarger JS, Ajayi TA, Jones BL (2014) Adolescents and young adults with life-threatening illness: special considerations, transitions in care, and the role of pediatric palliative care. Pediatr Clin N Am 61(4):785–796CrossRef

von Moers A, Müther S, Findorff J (2018) Transition als dringliche und gemeinsame Aufgabe. Monatsschr Kinderheilk 166(8):733–743CrossRef

Reinhardt D, Götz M, Kraemer R et al (Hrsg) (2001) Cystische Fibrose. Springer, Berlin/Heidelberg

Seidel M, Kappe C, Stockmann J et al (2020) MZEB: Ein wichtiges Angebot kommt nicht voran Medizinische Behandlungszentren für Erwachsene mit geistiger oder schwerer Mehrfachbehinderung. Westfälisches Ärzteblatt 05(20):24–26

Ullrich G (2014) Transition. Mehr als ein „Transfer“. Dtsch Arztebl 111(37):A-1508/B-301/C-237

Van Walleghem N, MacDonald CA, Dean HJ (2011) The Maestro Project: a patient navigator for the transition of care for youth with type 1 diabetes. Diabetes Spectr 24(1):9–13CrossRef

Watson AR (2000) Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 14(6):469–472PubMedCrossRef

Titel: Besondere Patientengruppen und praktische Herausforderungen
verfasst von: Georg Rellensmann
Ingeborg van den Heuvel
Kerstin von der Hude
Lars Garten
Silke Nolte-Buchholtz
Boris Zernikow
Mandira Reuther
Jens Berrang
Thomas Berger
Carola Hasan
Michael C. Frühwald
Tim Niehues
Ulrich Neudorf
Anne Schönecker
Uta Schürmann
Uwe Mellies
Heike Bredow
Caroline Gauch-Ayar
Michael Frosch
Bettina Hübner-Möhler
Andrea Beissenhirtz
Almut Hartenstein-Pinter
Hauke Schumann
Arne Simon
Pia Schmidt
Anna Kämper
Birgit Mertens
Barbara Gertz
Verlag: Springer Berlin Heidelberg
Buch: Pädiatrische Palliativversorgung – Grundlagen
Print ISBN: 978-3-662-61776-2

Electronic ISBN: 978-3-662-61777-9

Copyright-Jahr: 2021
DOI: https://doi.org/10.1007/978-3-662-61777-9_6

Neu im Fachgebiet Pädiatrie

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO₂. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

6. Besondere Patientengruppen und praktische Herausforderungen

Zusammenfassung

Neu im Fachgebiet Pädiatrie

Klimaschutz beginnt bei der Wahl des Inhalators

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Pädiatrie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Pädiatrie

Klimaschutz beginnt bei der Wahl des Inhalators

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Update Pädiatrie